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Cancer is the leading cause of death globally. The International Agency for Research 
on Cancer (IARC) recently estimated that 7.6 million deaths worldwide were due to cancer 
with 12.7 million new cases per year being reported worldwide. In the year 2018, the 
estimated total death was 9.6 million and globally, the number of cancer deaths are expected 
to increase from 18 million in 2018 to 29 million at the end of 2040 [1]. The cancer treatment 
was appreciated after the discovery of X-rays by Wilhelm Conrad Röntgen in 1895 [2]. The 
discovery of X-rays by Röentgen in 1895 led to the use of x-rays for diagnostics in hospitals 
throughout the world. The first medical x-rays at the University of Pennsylvania were taken 
in February of 1896 within 3 months after the discovery of the x-ray. The biologic effects of 
ionizing radiation were recognized. Experiments were performed by scientists and workers 
for experiencing a significant radiation effect. Physicians at St. Louis Hospital in Paris began 
treating patients with radiation after learning the effects of ionizing radiation. The use of 
ionizing radiation in the treatment of cancer began after they have found that radium can be 
used as an exposure to tumour [3]. 
Radiation therapy has been used in cancer treatment for many years ago [2]. Radiation 
uses the radiation techniques such as high-energy beams, X-rays, gamma rays, electron 
beams, or protons to cure cancer cells [4]. The main aim of radiation therapy is to maximize 
the radiation dose to abnormal cancer cells while minimizing exposure to normal cells. 
Radiation therapy has developed with speciality with Radiation Oncology being a discipline 
in which various health and science professionals from numerous disciplines work together, 
radiation therapy or radiotherapy remains an important modality used in cancer treatment [2]. 
Cancerous tumours can be treated using the following main methods such as chemotherapy, 
radiation therapy, and surgery. The radiation therapy is common to combine radiation therapy 
with surgery, chemotherapy, hormone therapy, or combination of the three techniques [3].  
Nuclear medicine is a phenomenon which uses radioisotopes for diagnosis, treatment 
or theragnosis (combination of therapy and diagnosis) [5]. Every year, over 10,000 hospitals 
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in the world uses radionuclides for diagnostics and treating about 30-50 million of patients 
according to World Nuclear Association and the European Commission [6].  Radioisotopes 
are isotopes of a chemical element with excess of energy, which they release in the form of 
radiation. They can occur naturally or be produced artificially in research reactors and 
accelerators. Research reactors and accelerators are used to develop new radioisotopes for 
diagnostics and therapy in nuclear medicine, for non-destructive testing and radiotracer 
industrial applications and to use as the radiotracer studies in scientific research. Accelerators 
advantages over nuclear reactors for radioisotope production, such as safety and cheaper 
operating and decommissioning costs. They generate less than 10% of the waste, it uses 
electricity rather than fission reactions and accelerator-produced waste is less hazardous than 
waste produced by a research reactor and accelerators do not pose risks to nuclear weapon 
proliferation [7]. 
 In the early 20th century, the use of radionuclides for treatment of disease has a long 
history and parallel isolation of radium by Marie and Pierre Curie. Radioisotopes are used for 
different application such as for medical product sterilization, cardiac diagnostic procedures, 
bone and tumour scans, and radioisotope therapy. Medical isotopes are produced by either 
reactors or cyclotrons. The neutron-rich radioisotopes, such as 99mTc, 60Co, 192Ir, 131I, 166Ho, 
177Lu, are produced in reactors either as fission products or though neutron capture analysis 
which are long-live radioisotopes. The neutron-deficient radioisotopes, such as 18F, 201Tl, 123I, 
67Ga, are produced in cyclotrons by the reactions of (p,n) and (p,α) and are short half-lived 
radioisotopes [8]. Most of the therapeutic radionuclides are produced in nuclear reactors and 
are rich in neutrons and decay by β- emission. The demand for the production of therapeutic 
radioisotopes is still growing. High-purity thermal neutrons spectrum is required to produce 
the therapeutic radioisotopes [9]. Nuclear research reactors are commonly used to produce 
medical radiolanthanides using a high thermal neutron flux for high yield production and high 
specific activity. For non-carrier added production route, large quantities of the target material 
will remain leading to low specific activity, this makes the direct pathway route of irradiated 
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target material to be impossible. The production of radioisotopes in reactors is based on 
neutron capture in a target material, either by activation or generation of radioisotopes from 
fission of the target material by bombardment with thermal neutrons [10]. Russia traditionally 
plays an important role in supplying isotopes to the world market, its share is estimated to be 
22% [11]. The following Figure 1.1 shows the countries nuclear reactor which are in 
commission of producing  177Lu [1]. 
 
Figure 1.1-The map showing global production of 177Lu nuclear reactors [1] 
177Lu-based radiopharmaceuticals have shown a growth in recent years among other 
radionuclides used for target therapy [12].  Several radiopharmaceuticals for treating of 
painful bone metastases have been developed and have shown good efficacy in relieving bone 
pain. Radiotherapy for bone pain is simple to administer and has been associated with 
improved mobility in many patients, reduced dependence on narcotic and non-narcotic 
analgesics, improved performance status and quality of life and, in some studies, improved 
survival. The use of 177Lu radiopharmaceuticals is under clinical trials in many countries, and 
it is expected that the approved 177Lu radiopharmaceuticals will be available in the near future. 
Its applicability has been studied in the treatment of colon cancer, metastic bone cancer, non-
Hodgkin’s lymphoma, lung, ovarian, and prostate cancer, and neuroendocrine and 
gastroenteropancreatic tumours [13]. The following Figure 1.2 shows that most of the 







Figure 1.2- Schematic representing the radiopharmaceutical product [10] 
 Radioisotopes 177Lu, is used in the form of labelled compounds for bone palliations, 
synovectomy, and the treatment of liver cancer [14].  177Lu is an important therapeutic 
radioisotope in nuclear medicine because of its high theranostic potential [10]. During the 
production of  177Lu at the research reactor, a specific activity is determined by the route of 
production. The main aim of the production of  177Lu for diagnostic and therapy methods  is 
to reduce the mortality rate from cancer [15].  The direct production route of  177Lu via the 
(n,γ) nuclear reaction which results in carrier added (CA) provide with limited achievable 
specific activity because of the presence of the target material. In order to obtain achievable 
specific activity, indirect route production of  177Lu using a highly enriched 176Yb target 
material which results in non-carrier added (NCA) may be used. The high specific activity of  
177Lu can be used for application of radioimmunotherapy (RIT) and peptide radionuclide 
therapy (PRRT) [16].  The main goal of this study was to perform the experimental production 
of NCA 177Lu with a recycling of the Yb target for nuclear medicine applications. The 
particular objectives of this research is to determine the theoretical activity calculations of 
177Lu from a given problem using the target Yb2O3, to separate of Lu from Yb using the 
cementation methods, to check repeatability of the experiment, to separate Yb from mercury 
by distillation process, to recycle the target (Yb2O3) through of separation of Yb and Hg using 
the distillation process and purification of mercury, to measure the activity of Yb and Lu using 
the well-type HPGe gamma-ray detector and calculate the activity and specific activity  of Yb 




Chapter 1- Literature review 
1.1 Therapeutic Particle Emissions 
 
Radionuclides emitting particles represent a high amounts of energy deposition in a 
small volume and are therefore suitable for most various cancers. The emission of therapeutic 
particles consists of Auger electrons, alpha particles, beta particles and conversion electrons. 
All these particles except for beta are classified as high-linear energy transfer (LET) electron 
emitters.  Conversion electrons are monoenergetic and have a discrete range in tissues, and 
beta electrons have range of energies, thus have a maximum and  average energy value [17]. 
Radionuclides that decay by β particle emission, α particle emission and auger electron 
emission are used in developing radiotherapeutic agent. Each type of particle emission has 
application treatment depending on the size of the tumor distribution, pharmacokinetics of the 
tracer. Beta emitters are frequently used for radiotherapy. The 𝛽−particles are emitted from 
the nucleus with the range of energy from zero to maximum level. The range of beta in tissues 
of 1-10 mm which provide homogenous tumor dosage through their deposition in 
heterogenous in the target tissues. Some particular radio-lanthanides produced in research 
reactor have similar chemical characteristics, their production and the use in therapeutic 
radiopharmaceuticals can be based on similar principles [18]. 
 Auger electrons are very effective in killing the cell to cellular DNA as a necessary 
requirement. Alpha emitting radionuclides are used for radiotherapy because of their high 
LET and its high cytotoxicity [19]. Alpha emitters are used for treatment of small and cluster 
cancerous cells and for medical application, alpha emitters are heavy particles with long-lived 
daughter products thus a small number of α particles can be used [18].  The altering of cellular 
homeostasis is another course of action, modifying signal transduction pathways, redox state, 
and disposition to apoptosis. The cellular changes enhance the killing of tumour cells while 
reducing the probability of normal cell death [20].The selection of a particle emitter depends 




 1.2 Decay scheme of 177Lu 
Lutetium (
177
71 Lu ) is a chemical element that belongs to the lanthanides group of the 
periodic table. The radioactive isotope with an atomic number of equals to 71 and the natural 
abundance which is 97.41% of the stable isotope of 
175
71 Lu  [21]. Lutetium-177 (half-life of 6.71 
days) decays by β- to the stable ground state of 177Hf and decays to an excited state of 177Hf 
that lies between 0.24967 MeV and 0.32132 MeV above the ground state, which de-excites 
to the ground state with the photon emission. The following Figure 2.1 shows the decay 
scheme for 177Lu [22]. 
 
Figure 2.1- Simplified decay scheme of 177Lu [22] 
177
71 Lu decays to 
177
72 Hf by beta decay as illustrated in the reaction Equation (1) and (2) below 
[21]. 
                                                       
0
en p e v
+ − −→ + +                                                               (1) 
                                                    
177 177
71 72 eLu Hf e v





1.2.1 Spectrum of 177Lu 
175
71 Lu  is both β
- and γ emitting isotope. The energy of β- particles which will give 
therapeutic effect are 498.3 keV at 79.4% of the total β- emissions. The post-therapeutic 
imaging energy that will be used is 208.36 keV at 10.36% of the γ emissions [21].  The tissue 
penetration depth of 0.5 MeV of β-  is 2 mm which allows selective deposition of energy inside 
the tissue cells while sparing the surrounding of the healthy tissues. The gamma emission and 
beta energies of 208 keV and 133 keV allows the simultaneous imaging and diagnostic of the 
treatment of tumor and make it possible for 177Lu to be used for theranostic. The advantage of 
the decay characteristics of 177Lu makes it advantageous by other applied therapeutic β—
emitters such as 131I and 90Y.The tissue penetration depth of 90Y is 11 m and that of 131I is 2 
mm but emits high energy photons in high abundance which results in extra radiation to non-
target organs, and 90Y damage the health surrounding tissues. The radioisotope 177Lu in 
comparison with 131I and 90Y, has the gamma rays which are sufficient low energy which 
allows for imaging while not affecting the nearby tissues, so it is considered a better 
alternative to 131I and 90Y for radio-therapeutic applications [1].  
1.2.2 No-Carrier-Added 177Lu  
Radionuclides have maximum theoretical specific activity values referred to as 
carrier-free when all the atoms contain one isotope of the element. Carrier free (CF) denotes 
a radionuclide having 100 % isotopic abundance. A radionuclide is characterized as no carrier 
added to which no carrier atoms have been added and for which precautions have been taken 
to minimize contamination with stable isotopes of the element in question. Carrier free is an 
idealistic situation for a preparation having a specific activity value that approaches the 





1.2.3 177Lu-Specific Activity 
The specific activity, 𝐴𝑠, for a given radionuclide is defined as its activity divided by 
the total mass of all its radioactive and stable isotopes which is measured in Bq/mol or Bq/g. 
Specific activity is expressed in terms of disintegration rate per unit mass of the element [17]. 
The Equation (3) can be used for determining the specific activity of the radionuclide 
produced by ( ,n  ):  





=                                                                           (3) 
where A  is the activity of the radionuclide measured and om is the initial mass of the 
lutetium in the irradiated target [23]. 
Lutetium-177-labeled therapeutic radiopharmaceuticals comprising small molecules, 
large biomolecules and particles are currently being evaluated for myriad of clinical 
applications [24]. The targeted radionuclide therapy is based on selecting appropriate 
radiopharmaceuticals and targeting mechanisms for application on the number of target sites 
available for radiopharmaceutical. For instance, targeting to trabecular bone is considered a 
large capacity site and does not require highly specific activity of 177Lu.  
The advantage to produce radioisotope using the nuclear reactor, is the ability to reach 
high specific activity. High thermal neutron flux in the nuclear research reactor allows 
production of medical radioisotopes with high specific activity [25].  High specific activity is 
used for applications such as receptors sites for peptide and antibody therapy. Therapeutic 
applications such as peptide radionuclide therapy (PRRT), radioimmunotherapy (RIT), 
palliative treatment of bone metastases etc. uses high SA 177Lu to express on the surface of 
the tumour [22]. Low specific activity can be used for applications in bone pain palliation and 
radiation synovectomy [25]. Specific activity of a radioisotope produced by particle-induced 
reactions is a direct function of the incident particle flux, an increase particle in the particle 
flux incident it results in an absolute increase in the specific activity of the product. Several 
isotopes have long physical half-lives and low production of cross-section which will require 
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long irradiation period. The increase of flux it does not only results in higher specific activity, 
but it will also result in conversion of the enriched target material. The increase of neutron 
flux for example, by a factor of two required half of the enriched target material to produce 
the same amount of radioactive product [10]. 
1.3 The importance of 177Lu for treatment of cancer 
The radioisotope 177Lu, is emerging as an important radioisotope for treatment of the 
cancer such as breast, prostate, colon, and brain. The isotope with a half-life of 6.71 days, 
emits a low energy β− with the maximum and average energies of 421 keV and 133 keV for 
the effective treatment of the small tumours. Also, it emits a low energy gamma radiation 
suitable for the simultaneous imaging. 177Lu is a radioisotope having very good potential for 
use in in vivo therapy, because of its favourable decay characteristic. This radionuclide is 
important in nuclear medicine as it emit gamma photons used for imaging and beta radiations 
used for therapy [26]. 
177Lu radionuclide has brought attention and, in the research, commercial and clinical 
communities for use in a variety of therapeutic procedures for over the last years. 177Lu has 
also established a strong foothold at the forefront of targeted radionuclide therapy (TRT).  
177Lu in a short time span has virtually pervaded all areas of in vivo radionuclide therapy and 
may be become a key therapeutic radionuclide of choice for targeted radionuclide therapy. 
The use of 177Lu in targeted molecular therapies has primarily developed for advances in 
molecular and cell biology, which include the use of peptides targeted to cell surface 
receptors, which are overexpressed on the surface of tumour cells [26]. 
The importance of 177Lu as a targeted radionuclide is that the β- emitted by 177Lu mean 
penetration range in soft tissues is 670 µm. Lu-177 emits β- particle which can penetrate 1 
mm in soft tissues, allowing effective delivery of radiation to tumour cells while sparing the 
nearby healthy tissues. The isotope is effective in localizing cytotoxic radiation in areas where 
the tumors developed. The emission of energy from β- and low energy photons results in low 
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dose and can be able to maintain high level activity of 177Lu during the preparation of 
radiopharmaceutical.  This property is important in medicine for the development of 
theranostic agents for combined diagnostic and therapeutic use that can deliver therapy to 
individual cells in affected tissues. 177Lu is a radionuclide which can be used for radiolabelling 
of antibodies and it offers the period to be elongated for other procedure such as purification 
quality control. 177Lu is an adequate radionuclide for therapy having both beta particle 
emissions with maximum energy of 497 (78.6%), 384 (9.1%) and 176 keV (12.2%) for 
therapeutic effect and gamma emissions 113 (6.4%) and 208 keV (11%) for imaging with a 
gamma camera. The major advantage of 177Lu lies in the feasibility of its large-scale 
production with excellent radionuclide purity and adequate specific activity owing to the high 
thermal neutron capture cross-section of 176Lu (2100 b) using moderate flux reactors [22]. 
The half-life of 177Lu which is 6.71 days offers extended time periods, which may be 
required for the use of more procedures to radiolabel and purify 177Lu-labeled 
radiopharmaceuticals, and for performing quality control and administration. The use of a 
longer-lived therapeutic radionuclide such as 177Lu is suited for the radiolabelling of 
antibodies that have slow targeting kinetics. The relatively long 6.71 days physical half-life 
of 177Lu not only minimizes decay loss, which may be encountered during the transportation 
and distribution to users, but also provides excellent logistical advantages for shipment to sites 
distant from the reactor production facility as well as radionuclide-processing facilities [22]. 
177Lu reactor production and processing technologies along with the recent 
developments are of great importance. As radionuclide therapy is moving to the forefront of 
molecular-targeted radionuclide therapy of cancer and other diseases, the demand for 177Lu is 
evolving. 177Lu production, it is essential based on the technical and economic resources. 177Lu 
has potential as a therapeutic radionuclide especially in developing countries with limited 
reactor facilities and for indigenous production capability of radiopharmaceuticals. The 
relatively longer half-life of 177Lu provides logistic advantage for production, radiochemical 
processing, and transportation of finished radiopharmaceuticals [17]. 
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1.4 177Lu Production Process  
The production of 177Lu in research reactors throughout the world indicates that all 
pertinent factors should be evaluated and assessed. The importance of production and 
processing strategy has been exploited to obtain 177Lu in a chemical form having acceptable 
radionuclide and radiochemical purity [27]. 177Lu is produced in a reactor by direct (n, γ) 
neutron radiation of the stable isotope 176Lu. 
 However, in the process, only about 20% of 176Lu atoms are converted to the wanted 
177Lu and it is very difficult to separate the radioisotopes from the non-radioisotopes since 
both compounds are chemically equivalent. Another method to produce 177Lu is through 
indirect process using the stable isotope 176Yb [26]. 177Lu can be produced by direct and 
indirect in the reactor production routes can be used for application in nuclear medicine. The 












1.4.1 Direct Production Route [176Lu(n,γ) 177Lu] 
The direct production route is based on neutron irradiation of 176Lu targets by the 
176Lu(n,γ)177Lu reaction. The direct production route offers the following advantages: The 
approach to target irradiation in a reactor and requires few design changes in reactor 
irradiation and processing facilities. It offers the potential to use the 176Lu2O3 target, which 
remains stable under irradiation conditions and is compatible with reactor irradiation. The 
irradiated target processing is easy, fast, and technically less demanding as simple target 
dissolution in dilute mineral acid on gentle warming suffices. The facility required for target 
processing is straightforward to install and maintain. The route has the flexibility to scale the 
increase or decrease levels of production in response to requirements by adjusting the target 
size. Processing generates negligible levels of radioactive waste, and this production method 
represents the most inexpensive option to obtain 177Lu of requisite purity [28]. 
175Lu and 176Lu are the two naturally occurring isotopes of lutetium and only 175Lu is 
stable radionuclide. 176Lu decays by beta decay with a half-life of 4×1010 years. For the 
production of 177Lu, the Lu2O3 is the preferred chemical form because of its chemical and 
thermal stability during irradiation and its solubility in dilute mineral acid. An enriched 176Lu 
target is of a great interest in view for the need to obtain high specific activity 177Lu amenable 
for radionuclide therapy. The targets used for production should have a high purity as isotopic 
impurities are likely to decrease the specific radioactivity of the produced 177Lu owing to high 
target nuclide burn-up during high neutron-flux irradiation [29]. Direct route production of 
177Lu provides with varying specific activities which depend on the neutron flux and 
irradiation time used and indirect route provide with specific activity which is closed to the 
theoretical specific activity calculated which takes into the account radioactive decay law 
[15]. The direct (n, γ) production route offers the prospect of producing 177Lu with specific 
activity adequate for preparing receptor-specific therapeutic radiopharmaceuticals. This is 
possible because 176Lu has a very high thermal neutron capture cross section (σ=2090 b, 
I0=1087 b) for formation of 
177Lu. The neutron capture cross section of 176Lu does not follow 
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the 1/v law, and there is a strong resonance very close to the thermal region. This method can 
be prepared with high specific activity of 177Lu with enriched irradiated 176Lu target [27].  
There are some concerns that have been raised on the use of this production route 
include despite the advantages of the direct route. The possibility of using enriched 176Lu 
targets is necessary owing to the limited natural abundance (2.6 %) of 176Lu in the unenriched 
target. The specific activity of 177Lu obtained by this method is 740–1,110 GBq (20–30 Ci)/ 
mg versus the theoretical SA value of 4.07 TBq (110 Ci)/mg. This indicates that only 25 % 
of the atoms are 177Lu, and 75 % consisting of the product mixture are non-radioactive which 
contaminate about 175/176Lu. The maximum specific activity can be achieved only with high-
flux reactors is about 70 % of the theoretical value. These specific activity values are adequate 
for preparation of the 177Lu-labeled agents used for bone pain palliation, synovectomy, 
treatment of liver cancer and some other applications activity [22]. 
1.4.2 Indirect Production Route [176Yb(n,γ) 177Yb β− 177Lu] 
The indirect 176Yb(n,γ)177Yb→177Lu production route necessitates a chemical 
separation of 177Lu from the target 176Yb target atoms. In order to obtain high specific activity, 
the indirect route of production can be considered using highly enriched 176Yb target material. 
The 177Lu produced by indirect method will be usable for all applications irrespective of the 
neutron flux in the reactor and irradiation conditions [15]. The indirect production route also 
has shortcomings, which may be expected to obstruct the path toward widescale utility. Low 
production yields due to the poor 176Yb thermal neutron reaction cross section (2.5 barn) as 
compared to the 2090 barn for the direct production from 176Lu. The effective separation of 
micro amounts of 177Lu from macro amounts of the irradiated Yb target requires an elaborate 
radiochemical separation as well as purification procedure in order to generate the significant 
amounts of radioactive waste. This method of production is the most expensive option to 
obtain 177Lu of requisite purity and it does not only require an enriched 176Yb target but also 
its recovery and recycling [27]. The advantage of using the indirect route production of 177Lu 
is the production of the radionuclide free from the long-lived 177mLu radionuclidic impurity 
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which is present when using direct route of production. The chemical separation of 177Lu from 
the irradiated Yb2O3 target material is the major challenge of producing 
177Lu using this route. 
The specific activity of the product will be reduced by the presence of Yb [25]. The indirect 
production route offers the potential to provide 177Lu of the highest possible radionuclide 
purity, the potential to provide 177Lu of the highest possible radionuclide purity and the 
presence of long-lived radioactive impurities (e.g., 177mLu, <10-5), below the detection limit, 
and is associated with minimum radiation protection and waste disposal issues. Specific 
activity is independent of neutron flux and it provide with the satisfactory radiolabelling 
performance. The 177Lu obtained by this method has a longer shelf-life (up to 2 weeks). This 
method of production is the most expensive option to obtain 177Lu of requisite purity and it 
does not only require an enriched 176Yb target but also its recovery and recycling activity [24]. 
Another production route has been proposed which is via 177mLu/177Lu as shown on 
Figure 2.2. The production route of 177mLu/177Lu radionuclide generator is based on the 
production of 177Lu from the decay of its long-lived isomer, 177mLu with a half-live of 160.4 
days [27]. The generator has brough challenges in the separation of chemically and physically 
alike isomers, 177mLu and 177Lu.  Recently, [27] have provided the experimental evidence on 
177mLu and 177Lu separation thereby confirming the possibility of 177mLu/177mLu radionuclide 
generator based 177Lu production [29]. Radionuclide generators have played an important role 
in the development and applications of radiopharmaceuticals [21]. 
177mLu/177Lu radionuclide generator can be used for the production of 177Lu 
radiopharmaceutical development by providing cost effective, carrier-free, on demand and 
onsite availability of 177Lu. The main challenges are the large-scale production of 177mLu, the 
parent radionuclide needed for the 177mLu/177Lu radionuclide generator. Is at the great 
importance if the nuclear research reactor infrastructure is available and capable of producing 
sufficient 177mLu activity to support the 177Lu generator production. 177mLu is usually co-
produced in small quantities during the direct route production of 177Lu [1].  
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1.5 Targeted Radiotherapy (TRT) 
The targeted radiotherapy is a field which have higher efficiency and less side effects 
to treatment of cancer than chemotherapy. The targeted radiotherapy (TRT) is the ability to 
deliver the radiation dose to cancerous cells even to unknown location of cancer cells 
developed which is the modality of treatment of cancer [22]. The targeted radionuclide 
therapy has radionuclides which are bounded to a target molecule to ensure there is interaction 
with the tumor cells. The radioisotopes are placed in the human body with cancerous cells by 
destroying the abnormal growth of cancerous cells by releasing the ionizing radiation during 
the radioactive decay. The biological effect of the targeted radionuclide therapy for tumor 
treatment is caused by the absorption of energy from the radiation emitted by the radionuclide. 
Targeted radiotherapy uses peptides or antibodies to cancer cells of which the specific 
receptors are over-expressed. This method ensures that there is a high degree of ionizing 
radiation that will focus only of cancerous cells without affecting the nearby healthy tissues 
[18]. This radionuclide therapy is effectively targeting the cancer cells inside the body of a 











Figure 2.3- Schematic diagram showing  the target radionuclide therapy using 
radiopharmaceutical comprising a targeting vector and lutetium-177 [1] 
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Targeted radionuclide therapy has been reported to be a success in the treatment of 
tumor with less side effects.  There are combinations of several factors for the application of 
any radionuclide in targeted radionuclide therapy such as physical half-life, decay energy, 
decay product, tissue penetration depth, high specific activity of the radionuclide, and 
radionuclidic purity [1].  The use of 177Lu in nuclear medicine procedures has been impressive, 
and widespread applications of 177Lu therapeutic agents and been responsible for stimulating 
the growth of these therapeutic methods. The use of 177Lu is evolving, as the targeted 
radionuclide therapy, and a broad spectrum of 177Lu labelled therapeutic radiopharmaceuticals 
for treating a wide range of diseases.  
In nuclear medicine the diffusion of 177Lu has not only brought the developments in 
radionuclide therapy but has also prompted radiotherapeutic method toward the treatment of 
some diseases. The remarkable use of 177Lu labelled radiopharmaceuticals in targeted 
radionuclide therapy have been the major factors among researchers and capturing the 
imagination of the clinical community though the advances in molecular and cellular biology 
[22]. The cost-effective availability of sufficient activity levels of 177Lu that have the required 
as the key success of using 177Lu in in vivo targeted therapy as 177Lu-labeled 
radiopharmaceuticals. The interesting use of 177Lu in targeted radionuclide therapy provide 
the review on the production and processing of this emerging radionuclide [22]. 
1.5.1 Basis of radiopharmaceuticals 
Radiopharmaceuticals are radioactive compounds used for diagnosis and treatment of 
diseases which consists of radionuclide and pharmaceutical agent. About 95% of 
radiopharmaceuticals in nuclear medicine is used for therapeutic purposes. The 
pharmaceutical is chosen in designing the radiopharmaceutical in a localized organ. The 
suitable radionuclide is chosen to be administered into the patient on the chosen 
pharmaceutical [19].  
The radiation emitted can be detected from the organ by external detector for 
assessment of structure and functioning of the organ. Several radiopharmaceuticals contain 
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177Lu for clinical trials. DOTA is the most studied peptide used for peptide receptor 
radionuclide therapy such as [𝐷𝑂𝑇𝐴0, 𝑇𝑦𝑟3] octreotide (DOTATOC) and [𝐷𝑂𝑇𝐴0, 𝑇𝑦𝑟3] 
octreotate (DOTATATE) which is labelled with 177Lu. DOTATATE is used to patient with 
somatostatin receptor-positive tumors e.g neuroendocrine tumors [24]. The 177Lu-
DOTATATE is FDA approved for treatment of gastroenteropancreatic, neuroendocrine 
tumors used for clinical applications worldwide. A paper was currently published for the 
treatment of prostate cancer using  177Lu-PSMA based radiopharmaceutical.  More than 50% 
of patients showed a respond of the treated cases. The 177Lu based radiopharmaceutical can 
also be used for application in breast, colon, lung cancer treatment [1].  
177Lu for radiopharmaceuticals has been successfully developed and evaluated. The in 
vivo applications of key 177Lu radiopharmaceuticals for a variety of therapeutic procedures 
include peptide receptor radionuclide therapy [29], bone pain palliation, radiation 
synovectomy [30] and radioimmunotherapy. There is an expanding list of 177Lu-labeled 
radiopharmaceuticals that is currently being evaluated at the preclinical research or at product 
development stages, these may be used in vivo in humans for evaluation for radionuclide 
therapy [26]. 
Lutetium exists in the +3-oxidation state, which precludes reduction oxidation in any 
chemistry solution complications and commonly forms nine coordination complexes. This 
property provides the potential for radiolabelling of molecular carriers, which include small 
molecules, and peptides, proteins, and antibodies with the specific desired characteristics for 
therapy. Lu+3 chemical characteristics are suitable for peptide and protein radiolabelling by 
attachment of a bifunctional chelating agent (BFCA) through a metabolically resistant 
covalent bond [22]. The major diagnostic modalities used for imaging which include both 
planar and tomographic imaging technology are single-photon emission computed 
tomography (SPECT) and positron emission tomography (PET) [21]. 
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1.6 Ytterbium target 
Natural ytterbium consists of a mixture of seven stable isotopes, including 168Yb, 
170Yb, 171Yb, 172Yb, 173Yb, 174Yb and 176Yb, among which 174Yb is the most abundant. The use 
of ytterbium metal as a target is considered for irradiation which oxidizes in air under oxygen 
[31]. The advantage of the use of Yb2O3 it possesses chemical and thermal stability during 
irradiation and the post irradiation target processing easy as simple target dissolution in dilute 
acid will suffice [32], and under irradiation in nuclear reaction has sufficient stability [24]. 
The concentrated acid is used to dissolve irradiated Yb metal. The isotopic abundance 
and their thermal neutron absorption cross section are summarized in the following Table 2.1:    
Table 2.1- Isotopic abundance of the natural Yb and thermal neutron absorption 








The possibility of obtaining a large-scale production of 177Lu by indirect route method 
it depends on the possibility of the radiochemical separation of the target Yb and 177Lu [33].  
If the enriched 176Yb is used instead of natural Yb as a target material for the production of 
177Lu, the specific activity expected to increase. Also using the enriched sample, 169Yb can be 
removed as an unwanted radioisotope, which is produced by neutron bombardment of 168Yb 
with very high σ(b), 2400 barn with these backgrounds.  
Isotope Abundance (%) σ (b) for (n,γ) 
168Yb 0.13 2400 
170Yb 3.04 12 
171Yb 14.28 53 
172Yb 21.83 1.3 
173Yb 16.13 16 
174Yb 31.38 63 
176Yb 12.76 31 
41 
 
1.7 Production equation 
Radionuclides are classified as neutron-rich and neutron-deficiency. The neutron-rich 
radionuclides are those that are produced in the nuclear research reactor while the neutron-
deficiency are produce by bombarding a target material with protons, deuterons, or helium 
particles and in most cases are non-carrier added radionuclides [17]. Radionuclides that 
undergo the neutron bombardment in the nuclear reactor, there is no Coulomb repulsion from 
positively charged nucleus, and these neutrons can easily penetrate the nucleus. Thermal 
neutrons have a low energy neutron with a large probability useful for production of 
radionuclides because these neutrons have distribution of energy of gas molecules in thermal 
equilibrium at room temperature [17]. 
The production of a given radionuclide is proportional to the number of the target 
nuclei tN , number of incident particles and the cross-section  . The radionuclide product 
undergoes radioactive decay, PN . Thus, the net rate of change in the number of radioactive 
product nuclei, pN during the irradiation is given by the rate of formation less the rate of 
decay, or [17], 
                                      /p t pdN dt N N = −                                                            (4) 
Since tN is large to remain constant during irradiation, the solution to this differential 
equation is,  
                                         (1 )
t
p tN N e
  −= −                                                           (5) 
The activity of the product pA , at the end of bombardment is PN , after the substitution 
the following radionuclide production Equation (6) is obtained, 
                                                      (1 )
t
p tA N e




 A -activity in disintegrations per seconds, dps; 
tN -number of target atoms= /W M F Avogadro constant (
236.023 10 atoms per mole); 
W - weight of the sample in grams; 
M -atomic weight in grams/mole; 
F -isotopic abundance; 
 - neutron flux in neutrons. 2 1.seccm− − ; 
  - cross section in 2cm ; 
 -decay constant of the product
1/2ln 2 / t= ; 
t - the irradiation time. 
1.7.1 Theoretical specific activity of 177Lu 
It is important to discuss the importance of the specific activity (SA) of 177Lu before 
its production and this is the key to success for the use in targeted radionuclide therapy [24]. 
The theoretical specific activity of carrier-free (CF) 177Lu is calculated using the following 
Equation (7): 
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where; N - number of 177 Lu  atoms,  - decay constant of 177 Lu ,  
1
2
T -  half-life of 177 Lu [24]. 
The following traditional equation (8) is used to project the irradiation yields [24]: 
                         
177 177 177dN Lu dN Lu dN Lu
growth decay
dt dt dt
   
= −   
   
          (8) 
OR                                                    
177
176 177 177 177dN Lu N Lu Lu N Lu Lu
dt
  = −                                                                       (9) 
where; 
176N Lu -number of target atoms 176 Lu ; 
176 Lu -neutron capture cross section of 176 Lu  ( 2cm ); 
177N Lu -number of radioactive atoms 177 Lu  formed; 
177Lu -decay constant of 177 Lu  ( 1s− ); 













177 177 177dN Lu dN Lu dN Lu
growth decay
dt dt dt
   
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LutN Lu N Lue −=  
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0N Lu =initial number of target atoms 
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                (10) 
The Equation (10) is used provides the neutron capture cross section in the thermal 
neutron area and is inversely proportional to the neutron velocity (the 1
Vn
law) [21].  
1.7.2 Irradiation Yield for indirect route production                                                                                   
                                                                               
(11) 
In this case, the net production rate of nuclide 177Lu is given by Equation (12): 




 −= −              (12)          
If the number of target atoms, YbN  , remains constant (no considerable target burn-up) 
and YbN = LuN =0 at t =0 (start of irradiation), integration of Equation (13) gives rise to:  
( )( )11 Yb Yb Lu dLu Yb Lu
dYb
t t tt t
t
Lu Yb Yb
Lu Yb Lu Lu Yb
e e ee e e
N N e
    


    
− − −− − −
−
 − − − −
 = + + 
− −   
              (13) 
where; 
YbN  - the initial number of 
176Yb atoms; 
 Yb  - is the cross section of the 
176Yb  (n,γ) 177Yb  reaction; 
 - the neutron flux of the irradiation source; 
 t - the irradiation time;  
dt - the decay time after irradiation,  
Yb and Lu  - decay constants of 
177Yb  and 177 Lu , respectively [19].  
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1.8 Research reactor for radioisotopes production 
In nuclear reactors, radioisotopes are produced mostly by (n,γ) reactions, they are 
neutron rich and decay by β− particle emission [34]. This route (n,γ) is widely used with 
thermal neutrons. The production of radioisotopes in reactors is based on neutron capture in 
a target material, either by activation or generation of radioisotopes from fission of the target 
material by bombardment with thermal neutrons. There are different types of neutrons which 
are classified according to their energy which are thermal, epithermal, and fast neutrons [34]. 
Thermal neutrons are those neutrons which are in thermal equilibrium with energy of 
0.025 eV at the temperature of 20◦C. The energy distribution can be represented by 
Maxwellian. Epithermal neutrons are neutrons which are moderated which have not reached 
thermal equilibrium. Their energy ranges are 1eV to ∼ 100 keV. The 1/En (where En is the 
energy of neutrons) law can approximately represent the distribution of epithermal neutrons. 
Fast neutrons are neutrons with high energy (above 0.1MeV). They have small significance 
in thermal reactors and for radioisotope production [34]. 
The uses of research reactors include the analysis and testing of materials, and 
production of radioisotopes. The applications are mainly in the nuclear industry, fusion 
research, environmental science, advanced materials development, drug design and nuclear 
medicine. It could also be used for academic and applied research in the areas of nuclear and 
neutron related sciences and engineering. The extent of the utilization of the reactor is 
basically determined by the reactor power, which determines the neutron flux available, as 
well as on its operational cycle. Small power levels and short operational cycles (only few 
hours of operation each day) are particularly inconvenient, both for high quality research and 
also for the production of useful radioisotopes [35]. The use of neutron activation for 
producing the radioisotopes, widely used in industry and medicine, by bombarding particular 
elements with neutrons analysis atoms are made radioactive by exposure to neutrons in a 
reactor. The characteristic radiation each element emits can then be detected [36]. 
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1.8.1 IRT-T research reactor 
The TPU Research Nuclear Reactor is the one and only in Tomsk and Russia 
determines its role in national and international research projects. The growth of interest in 
research activities in the area of neutron activation analysis (NAA). NAA allows measuring 
ultra-small concentrations of an element in substance and carrying out mass and express 
analyses. The University core scientific equipment includes the nuclear research reactor IRT-
T (W = 6 MW).  There are 14 vertical experimental channels (VEC) placed outside the reactor 
core and 10 beam ports (HEC): 8 radial beam ports with diameter of 100 mm and 2 tangent 
of 150 mm diameter [35]. Beryllium is used as the moderator.  The beryllium reflector has 
the thickness of 69 mm around the core perimeter. In the central channel, the maximum 
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Figure 2.4- Diagram showing the IRT-T reactor core [37] 
1.8.2 Neutron Activation Analysis  
Neutron activation analysis was first introduced by George Von Hevesy and Hilde 
Levi in 1936. It is a technique to measure amounts of chemical elements in a sample, based 
on the conversion of stable nuclei to other, mostly radioactive nuclei, by neutron irradiation 
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of the material [38]. The technique is based on the nuclear reaction between neutrons and 
target nuclei [39]. Neutron activation analysis (NAA) is also a technique used for qualitative 
and quantitative elemental analysis of multiple major, minor, and trace elements in samples 
and is the useful method for the determination of elements from various sources in the ppb-
ppm range without or with chemical separation [40]. 
Samples are bombarded with neutrons in order to transform stable isotopes of most 
element constituting samples into radioactive isotopes by neutron capture. The target is 
bombarded by neutrons such that neutron capture occurs, and atom will either remain stable 
or become unstable. If the nuclei are in an excited state and undergo β-decay emitting γ- rays, 
this can be detected using an HPGe detector [41]. The activated nuclides decay according to 
a characteristic half-life emitting beta particles only, but other nuclides emit gamma-photon 
with specific energies. The sensitivities and accuracies of neutron activation analysis are 
dependent on the concentration of a particular element and radionuclide parameters such as 
parent isotope abundance, neutron cross-section, half-life, and gamma ray abundance [38]. 
1.8.2.1 Types of Neutron Activation Analysis  
Instrumental neutron activation analysis (INAA) is based on short‐lived radionuclide 
production by nuclear reactions, such as reactor neutrons (i.e., thermal neutrons). INAA has 
advantages such as better sensitivity, low detection limit, simple and no reagent blank 
correction [42]. In INAA, the sample does not undergo chemical separation and can be used 
when other radioactive isotopes do not interfere with measurement of the element of interest.  
Radiochemistry neutron activation analysis (RNAA) involves sample decomposition 
and separation of elements. Through separation method, the interfering elements are separated 
from elements of interest [39]. INAA can be classified into two: prompt gamma ray neutron 
activation analysis (PGNAA) where measurements are performed immediately after 
irradiation and delayed gamma ray neutron activation analysis (DGNAA) where 




Figure 2.5- Method of NAA [40] 
1.8.2.2 Neutron sources 
The probability of a neutron interacting with a nucleus for a particular reaction is 
dependent on the kind of nucleus involved and the energy of the neutron. Isotropic neutron 
sources are most frequently used as neutron sources. They consist of an alpha emitting 
radioactive nucleus mixed with beryllium. The neutron sources are provided by neutron chain 
reactors utilizing the fission reaction and neutron irradiation is commonly used as an 
activation technique in a nuclear reactor. These neutron sources are applied in accelerators 
where a convenient target material is bombarded by accelerated charged particles and are 
produced in a nuclear reaction [41]. Neutrons are generated at a certain type of reaction has 
the advantage of the isotropic neutron sources which can be made portable and generate a 
stable neutron flux, but the neutron flux is rather low in comparison to a nuclear reactor [38]. 
The nuclear activation process can be expressed using the following Equation (14): 
      1 1 10 1
m m m





++ → +→                         (14) 
where; X - atomic number z and mass number m  of stable isotope, Y radioisotope which emit 
beta particle accompanied by gamma-rays, n - neutrons,  - gamma-ray released. 
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1.8.2.3 Cross section for Nuclear Reactions 
The probability of a neutron interacting with a nucleus for a particular reaction is 
dependent on the kind of nucleus involved and the energy of the neutron. The absorption of a 
thermal neutron in most materials is much more probable than the absorption of a fast neutron 
and probability of interaction will vary depending upon the type of reaction involved. [41]. 
The probability of a particular reaction occurring between a neutron and a nucleus is called 
the microscopic cross section (σ) of the nucleus for the particular reaction (Reaction Rates). 
The microscopic cross section is regarded as the effective area the nucleus present to the 
neutron for the reaction. The following Equation (15) shows the number of atoms at time t  
after irradiation is expressed as [41]: 
                                                            0
( )
0( ) ( )
y t t
y yN t N t e
− −
=              (15)                                                             
For a nuclear reaction of the type (n,γ), the induced activity ( tA ) in the disintegration 
per second at the end of irradiation of time (t) is given by Equation (16): 
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              (16) 
where   is thermal neutron capture cross section in 1sec− . The unit of cross section is 
the barn (1 barn= 10-24 2cm ),   is thermal neutron flux in neutrons 2cm− 1sec− ,  is decay 








t  is half-life of the product nuclide, N  is 
number of atoms of in the target [41]. 
1.9 Separation techniques of 177Lu from neutron irradiated 176Yb 
Radiochemical separation is a method which is considered for separation for success 
of NCA 177Lu production.  In periodic table, Yb and Lu are adjacent trivalent lanthanides and 
have similar chemical and physical properties. The separation of irradiation of 177Lu from 
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176Yb is the challenges for preparation of NCA which will require separation of microscopic 
levels of 177Lu from the macroscopic levels of the 176Yb target.  [33]. 
There is some consideration that must be followed to achieve the success which are, 
the specific activity of 177Lu must be higher and there should be a high decontamination 
factors from ytterbium provided by the separation process. The process should provide high 
yield of 177Lu (˃85%). The Lutetium should have a suitable chemical form (ionic form) for 
radiolabelling. The criteria for separation of Lu from Yb are the 177Lu/Yb separation 
efficiency and the time spent for this separation. The methods of separation of 177Lu from Yb 
are based on ion-exchange chromatography, solvent extraction, electrochemical separation, 
extraction chromatography. The separation is based on the difference in the properties of these 
elements such as the capability of Yb for reduction and amalgam formation [33].   
1.9.1 Cementation process for Yb and Lu 
Cementation is the method of electrochemical displacement of metals from 
compounds by other from their compounds. The process is based on the contact of alkali 
metal amalgams and acetate, citrate, or other compounds of rare earth metal. The 
cementation method is based on the selective reduction of ytterbium and its extraction on 
mercury by amalgamation [43]. The reduction is described with the following Equation 
(17):   
                                                        
3 2Yb Na Yb Na+ + ++ +                    (17) 
In this process, the irradiated Yb2O3 is dissolved in hydrochloric acid, sodium acetate 
is added to form sodium amalgam followed by extraction of Yb by sodium amalgam from 
Cl–/CH3COO– electrolytes taking advantage of higher solubility of metallic Yb than Lu in 
mercury. The procedure of this method has some limitation such that the recovery yield of 
177Lu and product quality is appealing, the time-consuming requirement at some point 
complicated the process by involving multiple cementation cycles together with the 
elaborate purification steps emerged as the major impediment that would be expected to 
restrict its wide-scale applicability [33].  
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The chloride ion addition in the form of their sodium or potassium salts increases the 
rate of cementation by sodium amalgam. Boldyrev et al. [43] suggested alternation of 
electrolysis on mercury cathode separation for the cementation reduction of Yb to eliminate 
the apparent technology imperfection. The electrochemical procedure for the Yb/Lu 
separation is electrolysis on a mercury cathode, based on the capability of Yb for reduction to 
the elemental state of the following reaction shown in Equation (18) followed by the formation 
of ytterbium amalgam [33]. 
                                                          
3 2 0Yb Yb Yb+ +→ →                    (18) 
Ytterbium amalgam in acid solution is unstable and decomposes immediately after its 
formation. The intense hydrolysis of trivalent elements is formed because of an increase in 
pH of the solution. The formation of amalgams is prevented due to the hydroxides formed.  
The electrolysis should be performed in neutral solutions of organic salts preventing the 
precipitation of hydroxides. The electrolysis on a mercury cathode is often accompanied by 
the mercury dispersion [33].  
This method is the separation of lanthanides with sodium amalgam. The method was 
reported by Lebedev et al. is based on the selection reduction of ytterbium and its extraction 
on mercury by amalgamation [24]. This method was optimised for the separation of NCA 
177Lu from 200 mg ytterbium target by Lebedev et al [44]. It is based on the selective reductive 
separation of ytterbium with sodium amalgam and followed by cation-exchange purification. 
The reduction is described as follows Equation (19):  
3 2Yb Na Yb Na+ + ++ +                                                 (19) 
The electro-amalgamation process is based on the mercury-pool cathode developed 
by Chakravarty et al. [45], which is based on the two-cycle in lithium citrate medium. This 
process provides 177Lu with > 99.99% Radionuclidic purity with an overall separation yield 
of ~ 99% within 3-4 hours [24].  
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The recovery of the target is important because of the high cost of enriched 176Yb. The 
recovery of the target from mercury amalgam needs chemical processing [46]. Dash et al. [24] 
demonstrated the flow chart of electro-amalgamation process which is used for routine 
production and chemical separation of 177Lu by indirect route production. The flow chart is 
show in Figure 2.6 below.  
 
Figure 2.6-Production flow chart [24] 
1.9.2 Electrochemical Method 
Electrochemical separation was applied for production of NCA 177Lu. Electrochemical 
separation strategy uses electrolytic medium to selectively deposit the radionuclide of interest 
between the standard reduction potentials of two radionuclides under controlled applied 
potential. This electrochemical method consists of selective reduction of Yb3+ to Yb2+ and its 
preferential transfer onto a mercury cathode exploiting the ability of Yb2+ to form amalgams 
with Hg [22]. There are some strategic methods that must be followed for the separation 
method such as the examination of the redox potentials of the Yb and Lu which indicates the 
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possibility of Yb forming the bivalent state and bivalent state of Lu is unknown. Yb2+ is known 
to form an amalgam, Lu3+ cannot [24].  
Therefore, Lu is difficult to deposit on the Hg cathode from aqueous electrolytes. The 
possibility of electrolytic reduction of Yb3+ to Yb2+ in acidic solution owing to its high 
hydrogen over-voltage. Such an attribute ensures no reoxidation of Yb2+ and offers easy 
handling and deposition of Yb onto Hg [24]. The electrochemical separation method is 
essentially based on the formation of the Yb amalgam by electrolysis into a mercury cathode 
or extraction into an amalgam aimed at its removal from the Yb-Lu mixtures [22].  
1.9.3 Purification of Yb from impurities 
Ytterbium (Yb) is a rare-earth element and in the earth's crust, is a mixed composite 
oxide mineral resource. Ytterbium metal has a high vapor pressure and is hard to refine and 
contains large amounts of volatile elements and the like as impurities [47]. It is possible to 
obtain high purity rare earth metals in which the oxygen content is 300 ppm or less and having 
few impurities. The refining method is proposed for obtaining high purity rare elements by 
adding Mg or Zn to Ta-containing rare earth metals as impurities, melting this in a crucible.    
High purity ytterbium can be obtained by heating ytterbium oxide in a vacuum 
together with reducing metals and reducing the product with reducing metals and 
simultaneously distilling the same. The purification of ytterbium involves the method of high 
temperature saturated dissolution, low temperature recrystallization, high temperature 







1.10 Radionuclidic purity  
The method of examination for gamma emitters for Radionuclidic purity is gamma 
spectrometry [89]. Radionuclidic purity is the ratio which is expressed as a percentage  of the 
radioactivity of 177Lu to the total radioactivity content of the sample.  Gamma spectroscopy is 
used to determine the Radionuclidic purity of 177Lu. For quantitative and qualitative analysis 
of 177Lu impurities, the detector must be calibrated for both energy and efficiency calibrations. 
The calibration sources that should be used is 152Eu containing radionuclides with different 
gamma photon energies [22]. 
1.10.1 High Purity Germanium (HPGe) detector 
Gamma rays are emitted during radioactive decay or nuclear reactions [49]. The 
detection of gamma gives  information about the nuclear energy levels in which their energy 
and intensity determines the position levels, the emission of gamma measure the lifetimes of 
levels in which it gives the deformation parameters, their polarization, their angular 
distributions, and the correction provide spin information, magnetic moment, and static 
quadrupole moments [50]. 
Gamma spectroscopy is a technique used to identify and measure radionuclides in 
different samples. The environmental samples can differ by chemical composition and 
structure for efficiency calibration for measurement of samples [51]. High resolution gamma 
spectroscopy is a method which is used to determine the radionuclides in any sample in which 
the radioactivity measurements are determined. This is achieved by means of HPGe detectors. 
HPGe is a semiconductor crystal detector which consists of a cylinder-shaped n type 
germanium crystal.   The high purity germanium detector is used for analysis of concentration 
of radionuclide in environmental samples and for environmental radioactivity. The calibration 
of the detector is important for the environmental radioactivity measurements, to improve 
efficiency and reduce the amount of radioactive waste produced. The calibration of the 
detector is performed by counting a sample and the standard source [52]. 
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Germanium(Ge) detectors have a large energy resolution which detect activity 
concentration measurements of different radioisotopes of different gamma emission [50]. 
High Purity Germanium (HPGe) detector has been used in many environmental studies to 
quantify the parent radionuclide in the samples on gamma peaks of its daughter radionuclide 
[51]. The detector used gamma ray interacting with matter to produce signals from particles 
entering the system. The energy of the gamma-ray is transferred to electrons creating electron 
pairs during the interaction [53]. Compared to well-type and planar, coaxial detector has low 
efficiency at low gamma energy [54]. Broad energy germanium detector (BEGe) is one of the 
HPGe detector which has high sensitivity at high gamma energy [51]. 
There is intrinsic uncertainty in radioactivity analysis. Uncertainty can be due to many 
components such as matrix, weighing, the content of water, radioactivity and homogeneity, 
instrumentations which include the special acquisition, background and efficiency calibration, 
and properties of nuclear which include radioactive decay, emission probability and the half-
life [55]. Long time of counting, large sample size and sample-detector distances that are 
small are recommended for better statistics when using the detector in gamma spectrometry. 
However, a sample with a large volume results in self-absorption and large counting time 
causing short-lived radionuclides to decay during the measurements [56]. 
 
Figure 2.7- An electronic system schematic for gamma-ray spectrometry [53] 
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Figure 2.7 shows a schematic diagram of for the electronic system of HPGe semi-
conductor detector. The detector is based on interaction of gamma ray with matter to produce 
a signal for every particle entering the system. The energy of the gamma-ray is transferred to 
electrons by creating electron on the active volume of material of the detector during the 
interactions. The number of charge carriers produced per interaction is proportional to the 
amount of gamma-ray energy deposited in the detector. External high voltage called detector 
bias is connected to the detector. The voltage withdraws the electron-hole pairs created within 
the depletions region of the detector for all the charge carriers are connected by the amplified 
to a proportional size of the gamma-ray energy absorbed [57]. 
BEGe can cover energy range from 3 keV to 3 MeV [58], it can be used in the 
application of nuclear physics [59], medical science [60] and the environmental studies. 
Monte Carlo (MC) is a simulation method used to calibrate the detector [61].  Bronson tested 
source less efficient calibration software using MC simulation for 13 detectors and concluded 
the method is more convenient quicker [58]. The Monte Carlo simulation was used to 
correction factors such as coincidence summing and self-absorption effects for some 
measurements [62].The Monte Carlo method has been applied to simulate the detection 
process to obtain spectrum peaks and to determine the efficiency curve for each geometry.  
HPGe‐detectors are calibrated for the energy response, peak resolution and counting 
efficiency using a multi‐channel analyser and the spectrophotometry software These 
properties depend on the energy of the incident radiation from 241Am/152Eu source with 
different gamma-ray energies. The detector characterization is performed using Genie 2000 
software [63]. The measured energy of a gamma-ray corresponds to the type of element and 
its isotope, while the number of counts corresponds to the abundance of the radioactive source 






 2.1 Chemicals and instruments  
The apparatus and equipment used in the experimental work are double distiller, 
analytical balance, muffle: for conversion to oxide, measuring beakers, pipettes, power 
supplies, chemical vessels, vacuum pump, liquid nitrogen, pH meter, heating stove, gamma 
spectrometer, cementation diagram, and vacuum mercury distillation plant. The solution used 
for all processes in this work were measured using a weighing balance and were prepared in 
the fume hood to eliminate the exposure to strong and hazardous chemicals. In the experiment 
processes for all the preparations, the deionized water was used. The required acids solutions 
were prepared by dilution of commercial concentrated HCl and HNO3. The glass columns and 
dispensers were washed with deionized water before preparations of solutions. After all 
experiment procedures, all radioactive waste solutions were collected and disposed in 
authorized storage area. All the solids, liquids were measured to check the level of 
radioactivity.  The preparations of reagents used, and their chemical structures are show in 
the following Figure 3.1: 
 
Figure 3.1- Chemical structures and formulas of different reagents prepared 
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 2.2 Energy and Efficiency Calibration 
The gamma-ray spectroscopy system is characterized by energy calibration, efficiency 
calibration and energy resolution. These properties should be measured using the source with 
different gamma-ray energies. The HPGe gamma spectroscopy detector was calibrated using 
152Eu standard source because it covers multiple gamma peaks of the entire region of interest 
and prior to the recording of gamma ray spectra. The detector was characterized using the 
152Eu source of range 121.78 keV to 1408.0 keV. The gamma photons from the 152Eu source 
were detected by introducing the source to the detector using sample changer. The detector 
was calibrated concerning efficiency calibration was performed.  
The calibration procedure of the detector is important to improve efficiency and 
reducing the amount of radioactive waste produce. Calibration is performed before measuring 
the sample to eliminate any shift spectra and maintain the quality of the measurements.  The 
efficiency calibration is done determining the full energy peak efficiency, as a function of 
energy using two low activity point sources with complex decay schemes. 152Eu was chosen 
because it consists of multiple energy peaks that cover a large energy region. After the 
calibration, the spectrum of 152Eu was obtained. The spectrum of 152Eu calibration of the HPGe 







Figure- 3.2 spectrum of 152Eu 
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The centroid channels were plotted against the energy peak lines for efficiency 
calibration, and the energy peak lines were plotted against the generated efficiency values 
[64].  Figure 3.3 below shows the efficiency as function of gamma-ray energy for the HPGe 
detector. 
 
Figure 3.3- Efficiency as function of gamma-ray energy for the HPGe detector 
 2.3 Theoretical 177Lu activity calculations 
The theoretical activity of 177Lu from 10 mg of Yb2O3 was determined using the 
irradiation time of 60, 1440, and 7200 minutes and with thermal neutron flux of 
134 10 n.cm-
2.s-1 using the Equation (6). 
2.4 Activation of solution using radioactive tracers (177Lu, 169Yb) 
The solution was activated using a radiative tracer of 177Lu and 169Yb. Radioactive 
tracers were made from irradiation of natural isotope of Lu and Yb at the nuclear research 
reactor. The mixed isotope of Lu which are found during the irradiation are 175Lu and 176Lu 
and the mixed isotope of Yb exposed to irradiation at the research reactor are 168Yb, 170Yb, 
179Yb, 173Yb, 174Yb, and 176Yb. The main target of isotopes during irradiation are 176Lu and 




















Efficiency and Energy curve
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 The radioactive tracer of 169Yb was used which can be made possible to conduct 
multiple technological experiments during the development of the method for the separation 
of ytterbium and lutetium. The use of radioactive tracers to is to determine the concentration 
distribution of the solution or to measure the activity of the sample.  
In the literature review, the mass ratio of Yb/Lu is in the range of 800-1200. The ratio 
between Yb/Lu was chosen to be 1000 for simplicity in the literature review. The 10 µg mass 
of Lu2O3 from the prepared radioactive tracers is equivalent to the 1000 ratio between Yb/Lu. 
The volume of HCl added was 5.85 ml with concentration of 2 M and the volume of sodium 
acetate added was 4.15 ml with concentration of 4.2 M into the solution.  In the prepared 
solution, there is non-radioactive 10 mg mass of Yb, 0.01 mg  radioactive Yb and radioactive  
0.01 mg (10/1000) of Lu.  
The following Figure 3.4 shows the activation of solution using a radiative tracer of 
177Lu and 169Yb. After the the target material of Yb2O3 exposed to radioactive labels, the 
reaction 177Yb (t1/2=1.9 hours)  from 








Figure 3.4 -Activation of solution using radioactive tracers (177Lu, 169Yb) 
10 mg of Yb2O3 was theoretically used in the study. This target material of 10 mg of 
Yb2O3, can be irradiated in the pool-type research reactor of the IRT-T with thermal neutron 
flux of 
134 10 n.cm-2.s-1. The irradiation can be carried out in a beryllium neutron trap (NT) 
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of the IRT-T reactor as shown in the Figure 3.5. The radioactive tracers have the same 
chemical properties as irradiation at the research reactor. 
 
Figure 3.5- Pool type nuclear research reactor IRT-T 
 2.5 Cementation process of Yb and Lu 
The cementation method was used for the separation of ytterbium and lutetium. The 
process of cementation was conducted from five cementations experiments each with three 
cycles of cementation.  
2.5.1 Yb translated into chloride 
The mass of non-radioactive of Yb2O3 target were weight as 10.2, 10.4, 10.3, 10.2, 
and 10.3 mg using an analytical weighting balance. The non-radioactive mass of Yb2O3 
represent the weight mass of first to fifth cementation experiment. The non-radioactive 10 mg 
Yb was translated it into chloride by dissolving it in hydrochloric acid and evaporate it into 
the heating stove as follows:  
                                   2 3 3 2Yb O HCl YbCl H O+ = +                                                         (20) 
        Balance equation: 2 3 3 26 2 3Yb O HCl YbCl H O+ → +                                                (21) 
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2.5.2 Five cementation experiments 
The gamma spectrometry was acquired using a high purity germanium detector 
coupled to a multichannel analyser (GX1018 Canberra). The solution containing HCl and 
CH3NOONa was measured for 7200 seconds using HPGe detector. The activity of Lu and Yb 
were measured in disintegration and the results were recorded. This was the initial 
cementation cycle measured before cementation process, to determine how many counts of 
Lu and Yb in the solution.  
5 ml of sodium amalgam (NaHg) was prepared per cementation experiment. The 
sodium amalgam was washed with water and ethanol. The amalgam starts to decompose, and 
a high amount of Na is needed. The amount of sodium amalgam was determined.  In the 
vessel, the solution containing hydrochloric acid and sodium acetate with radioactive Yb and 
Lu, and non-radioactive Yb were added into the sodium amalgam which contains molecules 
Na and Hg. The pH was continuously measured using pH meter as the solution was dissolving 
in the sodium amalgam. To keep the pH in the constant level, CH3COONa were added into 
the solution. After the chemical reaction between Yb and sodium amalgam, some amount of 
Yb and Lu was dissolving in Hg. After two minutes, the whole solution together with sodium 
amalgam was measured with HPGe detector. This was the first cementation cycle of the first 
cementation experiment. The activity of Lu and Yb were measured in disintegration and the 
results were recorded. After the first cycle of cementation measurement, the sodium amalgam 
was removed.  
After the first cementation cycle, the 5 ml of fresh sodium amalgam was prepared for 
the second cementation cycle. The fresh sodium amalgam was used in order to remove trace 
amount of Yb that may be present in the 177Lu. The dissolved solution from the first prepared 
amalgam was added to the fresh sodium amalgam. The solution was waited for two minutes 
to dissolve, and pH was continuously measured. The aqueous solution containing NCA 177Lu 
was separated and collected in the beaker. After two minutes, the whole solution together with 
sodium amalgam was measured with HPGe detector. The activity of Lu and Yb were 
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measured in disintegration and the results were recorded. This was the second cementation 
cycle of the first cementation experiment. The sodium amalgam was removed.  
Another fresh 5ml sodium amalgam was prepared for the third cementation cycle. The 
dissolved solution in sodium amalgam from second cementation cycle was added to a fresh 
sodium amalgam. The solution was waited for two minutes to dissolve, and pH was 
continuously measured using pH meter. After two minutes, the whole solution together with 
sodium amalgam was measured with HPGe detector. The activity of Lu and Yb were 
measured in disintegration and the results were recorded. And this was the thirst cementation 
cycle of the first cementation experiment. The sodium amalgam was removed. The second, 
third, fourth and fifth cementation experiment were conducted using the procedure of the first 
cementation experiment. The following Figure 3.6 show the process of cementation method.  
 
Figure 3.6-Diagram showing the solution procedure and cementation process  
2.6 Gamma spectroscopy measurements  
 
The measurement of activity concentrations of solution was carried out by γ-
spectrometry. The γ-spectra were acquired using a high purity germanium detector coupled 
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to multichannel analyzer (GX1018 Canberra). The HPGe detector has a 1.5 keV resolution at 
1333 keV and range from 1.8 to 2 MeV was used for analysis of 177Lu in the presence of Yb. 
 The solution was analysed by gamma ray spectroscopy using a HPGe detector after 
an appropriate dilution of the sample. These gamma-ray peaks were detected in the 
composition of the solution of Yb and Lu. The activity of Lu and Yb were measured in 
disintegration and the results were recorded. The following Figure 3.7 is the gamma 
spectrometry system used for measuring the activity of 177Lu and Yb. 
 
Figure 3.7- Block diagram of a basic gammas spectrometry system (GX1018 
Canberra) 
2.7 Distillation process experiment without radioactivity 
Distillation is the process commonly used for separating liquid mixtures in which a 
large amount of energy is used. It can be used separate mixtures in the chemical and 
pharmaceuticals industries [66]. The separation of the liquid mixtures depends on the 
differences in boiling points of the individual components and the components distribution 
between the phase of solid and liquid in the mixture. This process depends on the vapor 
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pressure characteristics of the liquid mixture, and this vapour pressure is formed by heat 
application as a separating agent [67]. Distillation process is used to separate Yb from mercury 
and purification of mercury, recycling Yb in new production. 
The distillation experiment without radioactivity was carried out at pressure of 850 
mbar (vacuum) with the volume mercury of 20 ml. After 20 minutes, mercury was boiled and 
evaporated at the temperature of 250-252° C. For 1 hour and 20 minutes, mercury left a minor 
amount of less than 0.5 ml. The installation was sacrificed with pre-washing 0.1 M of nitric 
acid (HNO3). Mercury pairs were controlled in the air with paper filled in a solution of Kl and 
Na. All mercury (with radioactive Yb) was distilled. Mercury was cleaned on filter paper 
(perforated) and falling into a receiver with 0.1 M nitric acid (HNO3). After 13 minutes, 
mercury began to boil at a pressure of 870 mbar and temperature of 246° C. The solution was 
filtered through filter paper in order to remove residual impurity of mercury/amalgam. The 
rate of evaporation was decreased. White powder with black enclosure (YbCl2) were obtained 
and during the cooldown, side surface red (HgO) and black (Hg2O) powder was obtained. 
White powder was obtained at the bottom of the flask.  
A 5 ml 4M of hydrochloric acid was poured onto the bottom of the distillation flask. 
All the powder was dissolved. Aliquots were selected at 1 ml. And the activity of Yb and Lu 
from the solution of the aliquots was measured using HPGe detector and the results were 





Figure 3.8- Vacuum Mercury Distillation Plant 
2.8 Activity and specific activity calculations 
Activity, A , is the term used to measure the decay rate of a radionuclide. Activity has 
units of disintegrations per second or dps. The decay constant,   represents the probability 
that a radioactive atom will decay and is dependent on the half-life of the nuclide [65]. The γ-
peak is used to calculate the activity of the isotopes. The activity of each cycle of cementation 
of Yb and Lu from five cementation experiments was calculated according to the Equation 
(22). 
 






=                                            (22) 
where; 
A -is the activity concentration of a certain radioactive nuclide in the decay series; 
I -is the number of counts (Area); 
 -is the absolute efficiency of the detector; 
Intensity -is the intensity of a specific energy photo peak; 
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t is time for collecting the spectrum of the sample [23]. 
The specific activity of a radionuclides produces by (n,γ) route of production is 
determined using  Equation (3).    
2.9 Radionuclidic purity 
Gamma spectroscopy is used to examine the Radionuclidic purity. The radionuclide 
impurities are directly related to the production process of a radionuclides. The technical 
limitations and safety requirements limits have been set for Radionuclidic impurities in 
preparations of radiopharmaceuticals which is expressed as a percentage of the total 
radioactivity [89]. Radionuclidic impurity of Yb and Lu was calculated form the final product 
using the Equation (23) and was expressed as a percentage of the total radioactivity.  





=                                                                (23) 
where; 
N - number of atoms of the radionuclide of interest;  









Chapter 3-Results and Discussion 
 3.1 Introduction 
177Lu is the isotope of interest which can be used for in-vivo target therapy 
radiopharmaceuticals. The production NCA of 177Lu is suitable for the development of target-
therapeutic agents.  In the last few years,  NCA 177Lu was produced in several papers and were 
reported [45].  The production of 177Lu by indirect method is ideal because only one isotope, 
177Lu, is produced in the process. However, the advantage of the preparation of this method 
allows the preparation of the product which correspond to the theoretical specific maximum 
activity of 110.91 Ci.mg-1 only during the measurement of impurities using different 
techniques required [33].  
177Lu separated by this method could be successfully used for preparation of high 
specific activity 177Lu-DOTA-TATE, an agent presently being used for treating in-operable 
neuroendocrine tumors over-expressing somatostatin receptors. And 177Lu obtained by this 
technique is suitable for the preparation of targeted therapy agents, with adequate purity as 
well as specific activity for radiopharmaceutical preparation [45].  
The aim of the study was to produce large amount of 177Lu by the indirect route 
176Yb(n,γ) 177Yb of production . It can be assumed that the 177Yb quantitatively decays to 177Lu 
due to the short half-life at high neutron flux and there are no significant losses through when 
it undergoes neutron activation to be expected. It is required to enrich the target material Yb 
to obtain a high irradiation yield and high specific activity of 177Lu.  
For this study, all reagents were prepared, the amount of 177Lu was produced by 
cementation process by separation of Yb from Lu. The distillation process was also used for 
separation of Yb from mercury, purification of mercury, recycling of target (Yb2O3) through 
the separation of Yb and Hg. The activity was measured using HPGe detector and all the 
results were recorded. 
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3.2 Theoretical activity of 177Lu calculations  




 during the irradiation time of 60, 1440, and 
7200 minutes were theoretically calculated. The theoretical number of atoms and activity of 
177Lu from Yb2O3 was calculated using Equations (7) and (6). Specific activity was calculated 
using the Equation (3). Table 4.1 Summarize the theoretical activity and specific activity of 
177Lu and are further illustrated in Figure 4.1. 




























3.4215 x 1019  
 
0.1033  
60 16.8 1.68 4.54 x 10-5 
1440 383.6 38.36 1.04 x 10-3 
7200 1573.6 157.36 4.25 x 10-3 





















 177Lu (Yb2O3)timeirr= 60 minutes










































during the irradiation time 60, 1440 and 7200 
minutes 
The theoretical activity during the irradiation time of 60, 1440, and 7200 minutes and 
was found to be 16.8, 383.6 and 1573.6 MBq with specific activity of 1.68, 38.36 and 157.36 
(MBq/mg), respectively.  
In Figure 4.1, the activity of 177Lu increases with irradiation time and attain a 
maximum activity.  The maximum activity corresponds to the when target started to irradiate 
in different time of irradiations. This shows during the production of 177Lu, it will reach a 
maximum point after a certain duration of irradiation. It is evident that the yield of 177Lu is 
achievable when the irradiation is carried out for the duration of 1, 3 and 5 days at the above 
specified thermal neutron flux. In some cases, there will be the decrease of the activity, and 
this could be a due to decay or rapid burning. According to theoretical predictions, the activity 
of 177Lu formed in the irradiated lutetium target is increasing linearly during the first several 
hours of the irradiation. Later the burn-up of the target material becomes evident and the 
irradiation yield reaches a maximum value [68]. 
The actual specific activity of 177Lu is different from the value obtained by dividing 
the production yield of 177Lu by mass of the target irradiated, since the actual mass of the 




























lutetium present in the system post irradiation is different from the initial mass of the irradiated 
target which is reported by Zhernosekov et al. [68].  The maximum values of the 177Lu specific 
activity are proportional to the thermal neutron flux.  
The specific activity of 177Lu from Yb2O3 provides for the possibility of variation of 
the time over the range without loss in the 177Lu yield, as well as the specific activity which 
is close to the theoretical value. The specific activity of 177Lu by indirect route of production 
depends on the amount of the lutetium in the target material. Even upon the irradiation with 
high thermal neutron flux (ϕ= 134 10 n.cm-2.s-1), the presence of stable lutetium isotope in 
the target material would lead to the decrease of specific activity of 177Lu [69]. The higher the 
thermal neutron flux of the reactor, shorter will be the time of irradiation for attaining 
maximum activity [69]. This applies when 177Lu is produced using enriched 176Lu. Therefore, 
to obtain a maximum specific activity using enriched 176Lu as a target material, the time of 
irradiation must depend on the neutron thermal flux for the irradiation [70].  
The specific activity is very important for quantity determination in nuclear medicine. 
The specific activity is related to the initial mass of the present element in the target when it 
is produced by the (n, γ) reaction. The radionuclides with high specific activity are required 
for application in nuclear medicine. A maximum specific activity is when the radionuclide is 
the only isotope of the element present in the system. If the burn-up of the target is neglected, 
the calculated specific activity agrees with the real value. If the cross section of the reaction 
is high, of which the target element is used during the irradiation process, the specific activity 
should be related to the actual mass of the actual mass of the respective element [68]. 
Lu-177 with specific activity that is higher than 15-20 Ci/mg is required for peptide 
receptor radionuclides [68]. Lu-176 has a high thermal neutron capture cross section among 
other lanthanides in which its activation product 177Lu decays into a stable, which does not 
compete with 177Lu during the labeling of radiopharmaceuticals [68]. During the indirect route 
production, NCA 177Lu is produced, the theoretical specific activity, however, can be obtained 
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when 176Yb is irradiated and completely separated from the 177Lu. The specific activity 
achieved can be lower because of the target ytterbium containing some stable lutetium 
impurity, the target is not monoisotopic which can contain few percent of 174Yb which causes 
the production stable 175Lu in the system via the reaction of 174Yb ( ,n  ) 175Yb→ 175Lu. This 
reason contributes to the total mass of lutetium mass in the system is significant due to the 
high 174Yb content in the target, the high thermal neutron captures cross section of 174Yb, and 
shorter half-life of 175Yb as compared to that of 177Lu. The other reason is that some amounts 
of ytterbium always remain in the system after the separation of Lu from Yb. During labeling 
of radiopharmaceuticals, ytterbium competes with lutetium, the specific activity must be 
related to the total mass of the lutetium and ytterbium in the system [68].  
 3.3 Cementation process results 
The production of 177Lu by indirect method depends on the possibilities of the 
radiochemistry separation of the starting of Yb and produced 177Lu. There are other different 
types of separation techniques to separate Yb from Lu (Electrolysis, Separation using the 
Resin, high performance liquid chromatography (HPLC). 
For separation of Yb and 177Lu, the efficiency required for separation is determined 
by relative concentration of Yb in the fraction of Lu [33]. The separation of 177Lu from 
ytterbium target is the key steps to determine the specific activity and Radionuclidic purity 
quality of the produced preparation of 177Lu. The mass ratio of Lu/Yb in the target is one of 
the properties to determine the success application of the selected separation method. The 
lower the mass ratio of Lu/Yb, the more feasible the separation [68].  
During cementation process, non-radioactive Yb2O3 was translated into chloride by 
dissolving it into hydrochloric acid and evaporate it into the heating stove. The introduction 
of the addition of the chloride in the form of sodium into the solution increases the rate of 
cementation by sodium amalgam. The cementation of the aqueous solution makes to process 
fast on sodium amalgam while increasing the pH of the solution depending on the duration of 
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amalgam, and the stirring method [43]. It is known that the cementation of aqueous solutions 
of ytterbium proceeds fast on sodium amalgam with the increase in pH of the working solution 
depending on the duration of contact with the amalgam [44]. 
Yb and Lu have the same chemical properties which is one of the disadvantages to 
separate the two isotopes. The cementation process was performed from five cementation 
experiment (each with three cementation cycle). Cementation process was conducted using 
different masses of Yb , namely 10.2, 10,4, 10.3, 0.2, 10.3 mg and 10 µg amount of Lu.  
Five different masses were used to verify the consistency and reproductivity of the 
procedure. For irradiation process of natural Yb2O3 target, the process leads to the 
coproduction of multicurie level of 175Yb as impurity. Though the 169Yb and 175Yb impurities 
could be efficiently removed by the separation process, this will give unnecessary radiation 
dose to the working personnel. The separation must be caried out in a lead shielded facility to 
provide radiation protection. The level of impurities in the irradiated target and in the final 
product can be minimized to a great extent using enriched Yb2O3 target [45]. 
3.4 Activity measurements results 
The initial cycle of the cementation was measured before the cementation process. 
The activity of the initial cycle of each cementation experiment was measured using a 
calibrated MCA coupled HPGe detector in disintegration. The activity was measure for 7200 
seconds. The energy and efficiency calibration of the detector was performed using 152Eu 
source covering the energy range from 121.78 keV (25.58 %) to 1408 (21%). The activity of 
the 177Lu was quantified by measuring the 208 keV (11%) gamma-ray peak and the amount 
of Yb present in it was determined by the 196 keV (35.9 %) gamma-ray peak emitted from 
the 169Yb isotope, respectively. The other gamma-ray energy peaks detected in the spectrum 
are 169Yb (130.5 keV), 175Yb (137.7 keV), 175Yb (144.9 keV), 169Yb (177.2 keV), 177Lu (208 
keV) and 177Lu (249.6 keV), respectively. Owing to its short half-life, 177Yb (T1/2=1.9 h), 
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would have been decayed and could not be detected in the sample. The gamma-ray spectra of 








Figure 4.2- Gamma-ray spectra of Lu and Yb mixture 
 The following Tables 4.2 to 4.6 shows the results of cementation of radioactive Yb 
and Lu of five cementation experiment. HPGe detector (GX1018 Canberra) was used to 
measure the disintegration of each cementation experiment. After the initial cementation cycle 
of each cementation experiment, the disintegration of the first, second and third cementation 
was measured using HPGe detector (GX1018 Canberra). 
















1 3233 9918 
2 1803 9003 
3 510 8162 
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Table 4.3- Cementation process of radioactive Yb and Lu disintegration results 
 
Table 4.4- Cementation process of radioactive Yb and Lu disintegration results 
            


















1 3160 9950 
2 1755 9041 















1 3352 10220 
2 1852 9280 















1 3258 9894 
2 1800 8992 
3 503 8114 
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1 3080 9416 
2 1715 8560 
3 483 7750 
 
From the above results, it was observed that the disintegration from the initial to 
the third cementation cycles of radioactive Yb and Lu decreases for each cementation 
experiments. The decrease of the disintegration corresponds to the different mass of 
radioactive Yb and Lu as the solution dissolves in sodium amalgam.  
The effects of macroscopic amounts of Yb on the cementation separation method 
of NCA 177Lu were investigated by conducting experiments using Lu/Yb mixture containing 
inactive Lu and Yb equivalent to 10 mg of Yb and 10 µg of Lu. The separation was carried 
out and the activity of the content of the recovered 177Lu was measured to determine the 
cementation separation yield. 
Table 4.7 Summarizes the results of the mass ratio of non-radioactive of Yb2O3 
and Lu2O3 from cementation experiment one to five of non-radioactive mass Yb2O3,  10.2, 
















Mass loss of 
Yb (mg) from 




Radioactive    
Mass of 
Lu2O3 
Mass loss of 
Lu (µg) from 
initial to third 
cementation 
cycles 
1 10.2 1.41 
10 
7.49 
2 10.3 1.43 7.47 
3 10.4 1.39 7.45 
4 10.3 1.40 7.42 







Figure 4.3 -Comparison of the mass differences between Lu and Yb on the separation of the 
Lu/Yb 
In Figure 4.3, this result shows the effect of the mass difference from first to fifth 
of each cementation experiment using the original mass of 10 mg of Yb2O3 and 10 µg of 
Lu2O3. In each cementation cycle, there are some variations of the loss of mass. As seen in 
Figure 4.3, the third cementation experiment is better than the first and second cementation 
experiments from 10 mg of Yb of the initial mass, and on the 10 µg of Lu, the forth 
cementation experiment is better that the first, second, third and fifth cementation experiment. 























Number of cementation experiments








Number of cementation experimenets
 10 µg Lu
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For these results, it is normal situation in separation methods to have reduction of 
mass. Yb is resisting in dissolving sodium acetate. The different of the initial masses (10.2, 
10.3, 10.4, 10,3 and 10.2 mg of Yb and 10 µg of Lu) shows that there were some errors during 
the dissolving of sodium acetate or preparation of sodium amalgam. This shows that each step 
of the experiment, different results were obtained. In the graph of 10 µg Lu, the first 
experiment has a big error, this shows in the graph that forth cementation experiment had a 
good accuracy.  
When conducting the same experiments, the accuracy was obtained as you can see in 
the graphs displayed in Figure 4.3. The errors between the first and third cementation is 1.5 
% difference, which is normal and good accuracy as compared to analytical methods having 
errors around 20 %. Therefore, this result shows it is good error and the results are accurate. 
In some circumstances, this can also be explained in terms of the effect of mass 
ration (Yb:Lu) of Yb/ Lu during the separation. For 10 mg of Yb2O3, the mass start to increase 
with number of cementation experiment, reaches a maximum point and start to decrease.  It 
can be observed that on the fourth and fifth cementation experiment, the mass of Yb start to 
increase. The slightly increase of mass of Yb shows that some amount of Yb might be left in 
the solution. This variation of masses can be used to explain the error attained during the 
experiment.  
For 10 µg Lu, the mass started to decrease from first and fourth cementation 
experiment and start to increase from fourth to fifth cementation experiment. It is shows that 
the amount of Lu in the solution was reducing during the separation of Yb/Lu. It is shown that 
the Yb and Lu can be separated completely with no overlapping and broadening on the two 
peaks. 
From this observation, these results indicate that the Lu can effectively separate from 
Yb target. The Yb/Lu mass ratio in the target is one of the properties to determine the success 
of the selected separation method. From above results, there is 7.14 times (10mg/1.4 mg) Yb 
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decrease, and 1.32 times (10 µg/7.6 µg) times decrease of Lu. The decrease can be 
implemented by increasing the number of cementation experiment. Therefore, the lower the 
Yb/Lu mass ratio, the more feasible the separation of Yb and Lu [67].  




















0 3670 10 10903 10 
1 3233 2.96 9918 9.09 
2 1803 1.65 9003 8.26 
 3 510 0.48 8162 7.49 
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(µg) left  
0 3593 10 10976 10 
1 3160 2.88 9950 9.07 
2 7155 1.59 9041 8.24 








Figure 4.5 -Comparison of the amount left between Lu and Yb after second 
cementation experiment 



















(µg) left  
0 3702 10 11884 10 
1 3258 2.99 9894 9.09 
2 1800 1.65 8992 8.26 
 3 503 0.46 8114 7.45 










































Figure 4.6 -Comparison of the amount left between Lu and Yb after third 
cementation experiment 




















0 3807 10 11300 10 
1 3352 2.97 10220 9.04 
2 1852 1.64 9280 8.21 





Figure 4.7-Comparison of the amount left between Lu and Yb after fourth 
cementation experiment 
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0 3504 10 10358 10 
1 3080 2.97 9416 9.09 
2 1715 1.66 8560 8.26 
 3 483 0.47 7750 7.48 
 
 
Figure 4.8-Comparison of the amount left between Lu and Yb after fourth 
cementation experiment 
Tables 4.8 to 4.12 shows the results of the amount of each cementation cycle with Yb 
and Lu from first to fifth cementation experiment. The results are further illustrated from 
Figures 4.4 to 4.8. The results show the effective separation of the macro quantities of 
ytterbium from the 177Lu/Yb mixture without the loss of 177Lu. In each cementation cycle, 
there is loss of mass. It is normal situation in separation methods to have reduction of mass. 
The results show the effect of mass of Yb and Lu dissolving in the solution. As shown 
on the Figures 4.4 to 4.8, Yb dissolve better than Lu. 177Lu has no amalgam which forms, it 
was reported that some amount of 177Lu can be removed from electrolyte with ytterbium [71]. 































 10 µg Lu
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Lu has no amalgam forming property where as Yb forms an amalgam readily and this property 
could be satisfactory exploited to achieve their separation. The results illustrated indicate that 
NCA 177Lu can effectively separate in the presence of 10 µg. Yb is resisting in dissolving in 
the sodium acetate. There are some forces which make Yb to resist in dissolving sodium 
acetate. After each cementation cycle, there are some chemical, physical forces acting which 
inhibit the Yb dissolving in mercury.  
Yb has a less impurities with large masses of non-radioactive Yb than Lu. This implies 
that one counts of Yb correspond to the larger masses of non-radioactive Yb. Lu has small 
non-radioactive mass, therefore, so to find the change in 10 µg of  Lu, more counts must be 
determined to be observable. 
As see in Figures 4.4 to 4.8, the graphs of Lu are straight line and the graphs of Yb 
are curvy or exponential. The straight line explains the fact that Lu has small mass and the 
inter-dependence of Lu and NaHg is too small.  
The process of dissolution is when one atom changes to another or is the consistence 
movement of molecules in the solution. When Yb and Lu dissolve in sodium amalgam, Yb 
takes away some amount of Lu. This means when Yb atoms moves to NaHg in a situation, it 
will transfer its atoms to Hg, therefore, it takes away some amount of atoms of Lu. Another 
reason is that the mass of Lu reduces faster than the mass of Yb because of the small mass of 
Lu, thus showing a straight line. 
After a total of five of these cementation experiments, an amount of the ytterbium was 
removed from the aqueous solution. The NCA 177Lu is isolated from the solution. The 
feasibility of cementation method, both in terms of yield and purity of the 177Lu, can be used 
for preparation of radiopharmaceuticals. 
As stated in the literature, the separation of neighbouring lanthanides is 
challenging. The effective separation of micro amounts of 177Lu product from macro amounts 
of Yb target material needs a special attention since high separation are required [72]. The 
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efficient method of the separation of the ytterbium and lutetium is based on the ability of the 
ytterbium to be reduced to the bivalent state on a mercury cathode in basic solutions in the 
presence a chelator [69]. A chelator can be introduced to modify the behavior of the two atoms 
with respect to the stationary phase [18]. 
The separation of Lu and Yb with sodium amalgam by formation of ytterbium 
amalgam was demonstrated by Marsh [73].  Lebedev described the attempt to application of 
the isolation process of 177Lu from irradiated Yb procedure [33].  The method reported by 
Lebedev et al [44] was involving eight cementation cycles. Chakraborty et al [74] reported 
the production of 175Yb by irradiation of natural Yb2O3 target material and 
175Yb labelled 
polyamino phosphate, as a potential agent for bone palliation [75]. 
The method was based on the selective ytterbium and its extraction on mercury by 
amalgamation. the target material Yb2O3 was irradiated and dissolved in hydrochloric acid, 
sodium acetate was also added to form sodium amalgam. The method was followed by 
extraction of Yb by sodium amalgam from Cl-/CH3COO
- electrolytes. The remaining of 
ytterbium and was then precipitated together with lutetium as hydroxides. The solution of 
177Lu obtained after precipitation was 1 mg Yb (III) from 50 mg of the irradiated target of 
Yb2O3 [24]. 
After the cementation cycle, the separation of 177Lu contained about 10 µg Yb (III) 
from 200 mg of neutron irradiated Yb2O3. In this cementation process, it was possible to 
precipitate macroscopic quantities of Yb up to 200 mg on Na (Hg) amalgam electrode. 
However, the use of mercury it was in a critical point for preparation of radiopharmaceutical 
grade radionuclides [44]. The cementation proceed should be repeated for 4 to 5 times in each 
cycle in order to separate 99% of ytterbium. The addition of the fresh amalgam requires a 
series of transitions operation, which leads to significant loss [33].  
Boldyrev came with an alternative suggestion of the cementation reduction of Yb with 
its separation by electrolysis on a mercury. The cementation process with sodium amalgam, 
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the electrolysis, is accompanied by the acidification solution and the process is repeated for 
the preparation of the second cementation cycle. This method of separation offers the higher 
purity benefit while reducing the overall times of processing. The method is simple, not 
susceptible to radiolytic damage and it generate minimum amount of radioactive waste and 
provides sufficient purity of 177Lu for nuclear medicine applications [33].   
The cementation separation method offers a benefit of higher purity product while 
reducing overall processing time. The method is inexpensive, not susceptible to radiolytic 
damage, generates minimum radioactive waste and provides sufficient purity for nuclear 
medicine applications. The experiment setup is robust, compact, easy to operate and amenable 
for making automated systems. This technique for producing NCA 177Lu could act as positive 
factor in the growth of 177Lu-based radiopharmaceutical [45]. 
 3.5 Distillation process results 
After cementation process, all mercury were collected and distilled. The following 
Table 4.13 shows the results of pressure and temperature with time during boiling point of 
mercury for distillation process which are further illustrated in Figures 4.9 and 4.10. The 
distillation experiment was performed without radioactivity at pressure of 850 mbar (vacuum) 
with the volume mercury of 20 ml.  
Table 4.13-Pressure and temperature with time during boiling point of mercury 
 
Time (min) Pressure (mbar) Temperature (°C) 
13 870 246 
22 880 252 
35 890 256 
57 900 254 











Figure 4.9-Dependance of temperature on time Figure 4.10-Dependance of pressure on  time 
In Figure 4.9, the temperature increases with time, it reaches a maximum point and 
start to gradually decrease. This happened when there is decrease of evaporation during 
boiling of mercury.  At the low time, the temperature is very small. The temperature at time 
25 minutes is 256 °C which is greater than the temperature at time 20 minutes which is 252 
°C, respectively. There is fluctuation of temperature during the heating. In the vessel, the top 
area is large, thus there is an increase of temperature during the evaporation of mercury. 
During the evaporation, the level area of the vessels starts to decrease. The decrease of 
temperature after 50  minutes, is due to the decreasing level of mercury  from the top of the 
vessel or because there was no mercury that is left in the vessel. 
The measurement of the experiment of the single vapor pressure of mercury, the 
boiling point was measured in 1801 by Dalton [76], who obtained 662 K and in 1803, Crichton 
[77], said that the normal boiling point is above a temperature. in this experiment, the vacuum 
pressure is relative pressure rather than an absolute pressure (0 mbar). In the initial, the 
vacuum pressure is more than the atmospheric air pressure. In the beginning of evaporation, 
the vacuum pressure decreases. In Figure 4.10, the vacuum pressure starts to increase at time 
13 minutes, in which at  point of 900 mbar reaches a maximum value and start to decrease at 
time 80 minutes. The pressure is not directly measured, rather is calculated from converting 



























the concentration of the mercury into a gas steam to a spatial pressure which is of the vapour 
pressure of the sample. Temperature and pressure depend on the level of mercury and 
evaporation. At the end of evaporation of mercury, the vacuum pressure increases, because of 
the pump, and in the vessels no evaporation is taking place. 
After the decrease of the rate of evaporation and cooling down of the solution in the 
vessel, white powder with black enclosure (YbCl
2
) were obtained and during the cooldown at 
the bottom of the flask, side surface red (HgO) and black (Hg
2
O) powder was obtained. The 
black powder (Hg
2
O) is not stable, it will transfer to red powder (HgO), this happens when 
the temperature of the vessel decreases. On the right vessel of the distillation plant, liquid 
mercury is left. 
5 ml 4M of hydrochloric acid was poured on the bottom of the distillation flask using 
a pipette. 1 ml of aliquots was selected, and the solution was measure in HPGe detector for 
7200 seconds. The hydrochloric acid was added to avoid the dissolving red and black 
powered. Table 4.14 Illustrate the results of the amounts of Yb (mg) and Lu (µg) dissolving 
in mercury (Hg) and Table 4.15 shows the disintegration results of Yb and Lu from 1 ml of 
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Table 4.15 -Results of the amounts of Yb (mg) and Lu (µg) left after dissolving in 
mercury (Hg) 
























The distillation process is used to separate Yb from mercury and purification or 
extractions of mercury. The amount of Yb and Lu dissolving in mercury are 44.33 mg and 
12.26 µg as shown in Table 4.14. The amount of Yb and Lu left after it has dissolved in 
mercury are 35.5 mg and 9.8 µg. The counts number of 12615 for Yb correspond to the  
amount 35.5 mg of Yb which can be recycled for a new production.  
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3.6 Activity and specific calculations 
The following Table 4.16 shows the results detected from gamma spectrometry of the 
initial cementation cycle before cementation process. 





The experiments on Yb amalgamation were performed at the room temperature while 
maintaining the pH at the constant level. The activity of each cycle of cementation of 
radioactive Yb and Lu was calculated using information from γ-line of 208 keV (177Lu) with 
intensity of 11.7 % and 198 keV (169Yb) with intensity of 34.9 %. From the results of Table 
4.16 of  gamma-ray line for 169Yb and 177Lu, Equations (22) and (3) was used to calculate 
activity and specific activity of Yb and Lu of each cementation cycle. The results are shown 
in Table 4.17 and are further illustrated in Figure 4.11. 
Table 4.17-Activity of the cementation cycles (disintegration) of Yb and Lu  
Energy 
(keV) 
Isotope Efficiency Intensity Counts Time (sec) 
198 Yb-169 0.096947267 0.349 2523 7200 
208 Lu-177 0.100563489 0.117 2130 7200 
Cementation no 
of cycles 
Activity of Yb 
(Bq) 
Specific 
activity of Yb 
(Bq/mg) 
Activity of Lu 
(Bq) 
Specific 
activity of Lu 
(Bq/µg) 
0 15±0.42 1.5±0.04 128.47±3.57 12.85±0.36 
1 13.20±0.37 3.22±0.03 116.62±3.07 11.66±0.31 
2 7.32±0.19 0.73±0.02 105.94±2.75 10.59±0.27 




Figure 4.11 Comparison between activity and specific activity of Yb and Lu calculated with 
cementation cycles 
The time used for measurement of  disintegration of 169Yb and 177Lu calculation was 
7200 seconds. As shown in the Figure 4.11, the activity and specific activity of Lu (red line)  
and Yb (black line) decreases. The activity of radioactive Yb and Lu after the of third 
cementation cycle were 2.06±0.05 Bq and 96.97±4.16 Bq which corresponds to 1.4 mg and 
7.6 μg, respectively. It evident that the activity and specific activity of Lu (red line) is higher 
than the activity of Yb (black line). And there is a rapid decrease of the activity and specific 
activity of Yb. 
3.7 Radionuclidic purity 
Radionuclidic impurity of Yb and Lu was calculated form the final product using the 
Equation (23) and was expressed as a percentage of the total radioactivity. The following 





















Lu-177 6.71 d 1.19 x 10-6 96.97 8.15 x 107 
8.97 x 107 
90.86 
Yb-169 32.02 d 2.50 x 10-7 2.06 8.24 x 106 9.18 
 
The Radionuclidic purity of 169Yb and 177Lu was found to be 9.18 % and 90.86 %, 
respectively. The effective separation of 177Lu from ytterbium target is one of the key steps to 
determine the quality (specific activity and Radionuclidic purity) of the produced 177Lu 
preparation. In order to obtain high specific activity of 177Lu is to separate 177Lu from the 
target material Yb as soon as after the end of bombardment and also to prevent the lower 
specific activity. This is because the isotope 175Lu formed by decay of 175Yb can lower the 
specific activity [45]. According to Knapp et al., [78] to produce 177Lu through direct route of 
176Yb ( ,n  )→ 177Lu provide lower production yield in comparison with direct neutron capture 
route.  This technique is an option which can be used for assessing NCA 177Lu using medium 
neutron flux nuclear research reactors and it can also make it possible for growth of 177Lu-
based radiopharmaceuticals [45]. 
The importance of 177Lu for labelled target specific radiopharmaceuticals is growing 
rapidly and the adequate specific activity and Radionuclidic purity is likely to increase with 
time globally [23]. When calculating the activity of Lu and Yb in the ( ,n  ) reaction, one 
should consider, the cross section for thermal neutron captures so as the target is not 
considered to be constant during the irradiation. The value of neutron flux for indirect 
production does not have effect on the quality of  177Lu obtained but the higher flux makes 
the makes the production more effective and it is easy to separate Lu/Yb. 
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Some amount of ytterbium always remains in the system after separation of Yb/Lu. 
Ytterbium competes with lutetium during labelling of radiopharmaceuticals, so the specific 
activity has to be related to the total mass of lutetium and ytterbium in the system [67].  The 
critical impurities are those which have the high abundance of the isotopes with high thermal 
neutron capture cross section and the half-life in the range of several days. Longer half-life of 
radionuclides is important because they increase the volume of radioactive waste which need 
to be stored or disposed in an appropriate way [67].  It is important after the 177Lu isolation, 
the target material 176Yb may be recycled and used for the repeated irradiation. This will 
however increase the efficiency of the utilization of the expensive target material [79]. 
South Africa is one of the countries that in commission of producing radioisotope 
177Lu. Maage and Knoesen [80] produced a non-carrier added 177Lu by indirectly irradiating 
enriched ytterbium-176 (176Yb) at SAFARi-1 nuclear research reactor of the South African 
Nuclear Energy Corporation (NECSA).  
 For indirect route of production, 1 g of 99.56% enriched 176Yb and Yb2O3 irradiated 
with a neutron thermal flux of 
145.94 10 n.cm-2.s-1 for  6-14 days followed by decay interval 
up to 14 days. The specific activity of indirect were 105.3 and 100.2 Ci/mg. After 14 days, 
the decay values decrease to 93.4 and 80.4 Ci/mg for indirect. The specific activity of NCA 
177Lu is 3.6 times higher than CA 177Lu. Therefore, the indirect route provides with high 
specific activity of NCA 177Lu preferred for peptide receptor radiation therapy (PRRT). This 
result shows that NTP at Necsa , has the ability to produce 177Lu which can be distributed in 
nearby radiopharmaceuticals facilitites and hospitals of South Africa and other neighbouring 
African countries for treatment of cancer and other diseases. 
The low activity obtained for this study can be used for biological synthesis of 
molecule, 177Lu-DTPA and other more applications.  As compared to the results in Table 4.16, 
this scientific study, the specific activity of 177Lu was low as compared to 105.3 and 100.2 
Ci/mg of Maage and Knoesen [80].  The results show a huge difference, and this might be 
due to the fact that the high amount of Yb was left in the final product, therefore the results 
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are comparable since the Yb separated from 177Lu using cementation separation technique. 
Therefore, to improve the results, the concentration of sodium acetate should be increased 
which has impact on the final activity of the product, to increase the cementation experiment 
to ten instead of five to reduce the amount of Yb in the final product. The NCA 177Lu is 
possible to deliver to the end medical users from the production facility and radionuclide-
processing facility, because 177Lu has the relatively long 6.71 days physical half-life of and 
will not only minimizes decay loss but may also be encountered during the transportation. 
Tomsk polytechnic university creates the trial batch of chemical element lutetium 
which is used for the treatment of cancer. The scientists of TPU were the first to produce 
radioisotope 177Lu at the IRT-T reactor. The isotope is still used in the leading clinic in 
Germany and Israel. The IRT-T research reactor can produce 177Lu by direct and indirect route 
This shows that TPU is of importance in the Tomsk Regions and the entire country of Russia, 
since it can produce this 177Lu radioisotope which can be distributed to hospital for nuclear 
medicine application in treatment of cancer [81].  
The developed technique of cementation separation technique for separation of NCA 
177Lu from Yb through activation of solution using radioactive labels of the could be used for 
the routine production of NCA 177Lu, especially in the developing countries with limited 









Chapter 4-Financial management, resource efficiency and resource saving 
Financial management is the activity of management concerned with the planning, 
procuring and controlling of the firm's financial resources. “Financial management may be 
defined as that area or set of administrative function in an organization which relate with 
arrangement of cash and credit so that organization may have the means to carry out its 
objective as satisfactorily as possible." - by Howard & Opton. 
The purpose of this section discusses the issues of competitiveness, resource 
efficiency and resource saving, as well as financial costs regarding the object of study of 
Masters' thesis. Competitiveness analysis is carried out for this purpose. SWOT analysis helps 
to identify strengths, weaknesses, opportunities, and threats associated with the project, and 
give an idea of working with them in each particular case. For the development of the project 
requires funds that go to the salaries of project participants and the necessary equipment, a 
complete list is given in the relevant section. The calculation of the resource efficiency 
indicator helps to make a final assessment of the technical decision on individual criteria and 
in general. 
In addition, it would help determine the accomplishment of the research work so as to 
develop a mechanism for managing and supporting specific project solutions at the 
implementation stage of the project lifecycle to increase productivity. The financial 
management solves the following objectives: 
• Planning and preparation of research work. 
• Budget calculation for research work. 
• Development of evaluation of commercial potential. 
 4.1 Pre-research analysis  
To analyze consumers of research results, it is necessary to segment the market. This 
research focuses on production of 177Lu by indirect route method using non-radioactive 
Yb2O3. Radioactive tracers 
169Yb and 177Lu were used for activation of solution. Yb and Lu 
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must undergo separation process after activation. Cementation method was used to separate 
Yb from Lu. A trace amount of Yb and Hg was found in the solution, distillation process is 
used to separate Yb from mercury and purification of mercury, recycling Yb in new 
production. 
Target market - the market that includes consumers interested in the results of the 
research who would buy the good/service connected with the student’s investigation. For this 
research, the 177Lu produced in the study can be distributed to radiopharmaceuticals 
companies and hospital would use the results for treatment of cancer. 
Segmentation is the division of buyers into homogeneous groups, each of which may 
require a specific product (service). It is possible to apply geographic, demographic, 
behavioral and other criteria for segmenting the consumer market, it is possible to use their 
combinations using such characteristics as age, gender, nationality, education, favorite 
occupations, lifestyle, social affiliation, profession, income level. Depending on the category 
of consumers (commercial organizations, individuals), appropriate segmentation criteria must 
be used. For example, for commercial organizations, segmentation criteria can be: location; 
industry; manufactured products; size, etc. For individuals, segmentation criteria can be: age; 
gender; nationality; education; income level; social belonging; profession, etc. 
4.1.1 Competitiveness analysis of technical solutions  
  In order to find sources of financing for the project, it is necessary, first, to determine 
the commercial value of the work. Analysis of competitive technical solutions in terms of 
resource efficiency and resource saving allows to evaluate the comparative effectiveness of 
scientific development. This analysis is advisable to carry out using an evaluation card (see 
Table 5.1). 
The outcome of the research is very sensitive on producing radioisotope of interest 
for nuclear medicine applications. The production route is indirect route where Yb target is 
enriched before irradiation. The cementation method was used for the separation of 
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ytterbium and lutetium followed by distillation process used to separate Yb from mercury 
and purification of mercury, recycling Yb in new production. The measurement of activity 
concentrations of Lu in the presence of Yb was carried out by γ-spectrometry. The γ-spectra 
were acquired using a high purity germanium detector coupled to multichannel analyzer 
(GX1018 Canberra). 
However, this project tends to focus more on the nuclear medicine and all related 
medicine industries produces isotopes for treatment of cancer. In these medical industries, 
large number of radioisotopes are tested and the development of radiopharmaceuticals using 
radioisotope 177Lu are under clinical trials. Therefore, this research was embarked to reduce 
the time of examination and to reduce the cost involved to enrich Yb target since is expensive 
and to reduce large amount of nuclear waste materials. This ultimately leads to a reduction 
in the economic costs of purchasing and enrichment of Yb target material. 
There are different types of separation methods used to separate NCA 177Lu from Yb 
which can also be considered: 
• Cementation process – fP . 
• Electrochemical method – 1iP . 
• High pressure liquid chromatography – 2iP . 
Cementation process was used and appeared to be an attractive method and feasible 
proposition. The cementation separation method offers a benefit of higher purity product 
while reducing overall processing time. The method is inexpensive, not susceptible to 
radiolytic damage, generates minimum radioactive waste and provides sufficient purity for 
nuclear medicine applications. 
First of all, it is necessary to analyze possible technical solutions and choose the best one 
based on the considered technical and economic criteria. 
Evaluation map analysis presented in Table 5.1. The position of your research and competitors 
is evaluated for each indicator by you on a five-point scale, where 1 is the weakest position 
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and 5 is the strongest. The weights of indicators determined by you in the amount should be 
1. Analysis of competitive technical solutions is determined by the formula: 
                                 𝐶 = ∑ 𝑃𝑖 ⋅ 𝑊𝑖 ,                        (24)      
where;                     
С - the competitiveness of research or a competitor; 
Wi– criterion weight; 
Pi – point of i-th criteria. 
Table-5.1- Evaluation card for comparison of competitive technical solutions 









weighcoefficients       
1 2 3 4 5 6 7 8 
Technical criteria for evaluating resource efficiency 
1. Growth in User’ productivity 0.15 4 3 3 0,5 0,5 0,06 
2. Convenience in operation 
(meets the requirements of 
consumers) 
0.02 4 3 4 0,6 0,4 0,3 
3. Immunity 0.05 3 3 3 0,5 0,03 0,05 
4. Energy efficiency 0.2 3 4 4 0,2 0,15 0,5 
5. Reliability 0.05 3 4 3 0,2 0,2 0,4 
6. Safety 0.05 4 4 3 0,5 0,2 0,5 
7. Noise level 0.02 2 3 3 0,6 0,15 0,4 
8. Demand for memory 
resources 
0.05 3 3 4 0,3 0,04 0,3 
9. Functional capacity  0.15 4 3 3 0,5 0,3 0,06 
fP i1P i2P fC i1C i2C
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10. Ease of operation 0.02 5 4 3 0,4 0,5 0,5 
11. Intelligent interface quality 0.02 3 4 3 0,3 0,2 0,2 
12. Ability to connect to a 
computer network 
0.05 4 3 3 0,05 0,06 0,02 
Economic criteria for performance evaluation 
1. Development cost 0.1 5 4 3 0,6 0,4 0,05 
2. Market penetration rate 0.02 3 3 3 0,04 0,06 0,06 
3. Expected lifecycle 0.05 3 3 3 0,4 0,3 0,04 
4. Price 0.05 3 3 4 0,05 0,6 0,2 
5. After-sales service 0.02 4 3 3 0,06 0,2 0,6 
6. Estimated life-time 0.02 4 3 3 0,04 0,5 0,4 
Total 1 64 60 58 5,85 4,79 4,64 
 
The results of the competitiveness analysis show that cementation process have the 
highest value of competitiveness. This shows that the cementation process is the best for 
feasible separation of Yb from Lu.  The study is effective because it provides acceptable 
quality results. Further investment in this development can be considered reasonable. 
4.1.2 SWOT analysis 
Complex analysis solution with the greatest competitiveness is carried out with the 
method of the SWOT analysis: Strengths, Weaknesses, Opportunities and Threats. The 
analysis has several stages. The first stage consists of describing the strengths and weaknesses 
of the project, identifying opportunities and threats to the project that have emerged or may 
appear in its external environment.  
Strengths. Strengths are the factors that characterize the competitive side of a research 
project. Strengths indicate that a project has a distinctive advantage or special resources that 
are special in terms of competition. In other words, strengths are the resources or capabilities 
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available to the project management that can be effectively used to achieve the goals set. At 
the same time, it is important to consider the strengths both from the point of view of the 
project management and from the point of view of those who are still involved in it. 
Weaknesses. A weakness is a flaw, omission, or limitation of a research project that 
hinders the achievement of its goals. This is something that does not work well within the 
project or where it has insufficient capabilities or resources compared to competitors. 
Opportunities include any preferred situation in the present or future that occurs in 
the project environment, such as a trend, change, or perceived need that supports the demand 
for a result that allows the project management to improve their competitive position. 
Table 5.2-SWOT matrix 
 Strengths of the research 
project: 
S1. Energy and Efficiency 
calibration of HPGe 
detector. 
S2. Able to work in high 
activity in the laboratory 
results using gamma 
spectroscopy and results 
analysis. 
S3. Production costs is 
low. 
S4. Does not require 
higher electrical energy to 
operate. 
Weaknesses of the 
research project: 
W1. All reagents, 
chemicals and data of 
results were prepared and 
collected by qualified 
stuff. 
W2. Data collections of 




S5. Reduction in time for 
the collection of data. 
Opportunities: 
O1. The data collection of 
activity can be used to 
calculate the specific 
activity of the 177Lu final 
product using gamma 
spectroscopy (GX1018 
Canberra).  
O2. Calibration of the 
detector using mixed 
standard sources. 
O3. Data will be 
applicable in TPU for 
record to be used in future 
analysis. 
O4. To use other 
technique for precise and 
accurate of the results. 
O5. The optimization of 
other separation method. 
1. To obtain other 
methods to 
calibrate the HPGe 
detector. 




of the yield 
product. 
3. To produce high 
activity of 177Lu 
using a different 
route of production. 
4. To create a new 
direction of 
production of 177Lu 
to be used for 
diagnostics and 
imaging. 








2. To obtain data in 
record time and 
according to the 
research planning. 
Threats: 
T1. Lack of hands on in 
the working laboratory. 
 T2 Lack of demand for 
the use of another 
Strategy which based on 
strengths and threats: 
1. Improve the 
opportunity of 
student hand on 
Strategy which based on 
weaknesses and threats: 
1. The collection of 
the results took 
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technique, such as beta 
spectroscopy. 
T2. 1. Strong competition 




2. The ability to use 
beta spectroscopy 
to be able to 
identity other beta 
radionuclides 
needed for the 
study.  
time due to lack of 
involvement. 





awareness of the 
scientific research. 
 
The challenges of this research based on conclusions can easily be solved and overcome for 
future. 
4.2 Project Initiation 
The initiation process group consists of processes that are performed to define a new 
project or a new phase of an existing one. As part of the initiation processes, the initial goals 
and content are determined, and the initial financial resources are recorded. The internal and 
external stakeholders of the project that will interact and influence the overall outcome of the 
research project are identified. This information is fixed in the project Charter. The project 
charter documents the business needs, the current understanding of the needs of the project 
customer, as well as the new product, service, etc. is the result that is planned to be created. 
4.2.1 The goals and results of the project  
This section provides information about the project stakeholders, the hierarchy of 
project goals, and the criteria for achieving the goals. Project stakeholders are persons or 
organizations that are actively involved in the project or whose interests may be affected both 
positively and negatively during the execution or as a result of the completion of the project. 
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They can be contractors, sponsors, the public, etc. Provide information on the project's 
stakeholders. 
 
Table 5.3-Stakeholders of the project 
Project stakeholders Stakeholder expectations 
Research Institute (TPU reactor-
IRT-T) and other nuclear 
research Institutions producing 
radioisotopes, and 
radiopharmaceutical 
The approval of the scientific research was 
done under TPU. 
To produce radioisotopes with high specific 
activity using direct and indirect route for 
nuclear medicine applications.  
To using the produced yield of 177Lu for 
preparations of radiopharmaceuticals. 
Hospital and 
radiopharmaceutical companies 
The radioisotope 177Lu to be transferred to 
radiopharmaceutical companies and hospital 
institute for special treatment. 
People with cancer disease and 
experimental methods 
To use radiopharmaceuticals 177Lu to be 
administered for treatment of cancer by 
minimizing the neighboring tissues and to be 
used for synthesis of biological molecules. 
South African government 
companies that produces 
radioisotopes 
To embarkment of knowledge and experience 
gained to put in the resources of South Africa, 
since it has technologies to produce the 








Table 5.4- Purpose and results of the project 
Purpose of project: 
To perform the experimental production of NCA  177Lu 
with a recycling of the Yb target for nuclear medicine 
applications. To separation of NCA 177Lu from macroscopic 
amounts of the ytterbium target material by cementation 
process based on sodium amalgam and recycling of target 
(Yb2O3) through of separation of Yb and Hg using the 
distillation process. 
Expected results of the 
project: 
Low activity of 177Lu and high amount of Yb in the final 
product was observed which can be used for biological 
systhesis of molecules and 177Lu DTPA. 
Criteria for acceptance of 
the project result: 
The results must be improved by to carry out optimization 
for better separation of Yb and Lu. 
To recycle the Yb amount obtained for new production of 
177Lu.  
Requirements for the 
project result: 
The results must be in agreement with other published 
authors. 
 
Further studies should be conducted using the results 
obtained. 
To use alternative separation method to reduce high 
amount of Yb in the production yield. 
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Industrial application: the results would help in other 
nuclear medicine application which requires a low activity 
of 177Lu. 
 
4.2.2 The organizational structure of the project 
 At this stage of the work, the following issues need to be resolved: who will be 
included in the working group of this project, determine the role of each participant in this 
project, and also specify the functions performed by each of the participants and their labor 
costs in the project. In this research work, there were four participants. 
• Scientific supervisor  
• Consultant 
Table 5.5- Working group of the project 
№  Participant Role in the project Functions Labor time, 
hours × (6 
hours) 
1 Naymushin Artem 
Georgievich, 
Deputy Director-





Scientific Supervisor Responsible for 
authorization and 
implementation of the 
resources used, and 
coordinated the 
activity of the 
scientific research. 
18 x 6= 96 
2 Veronica Kgabisang 
Gouws, TPU 
masters student 
Executor Introduction and 
Review of literary 
writing, experimental 
33 x 6= 198 
105 
 
method format, results 
discussions, 
conclusions,   
Writing the master’s 
thesis. 






Consultant Proposed a scientific 
research topic, aim 
and objective of the 
study. Review results, 
discussions and 
conclusions of the 
study. Corrections on 
the format of the 
dissertation, grammar, 
results analysis. 
79 x 6= 474 
Total 768 
 
4.2.3 Project limitations 
Project limitations are all factors that can be as a restriction on the degree of freedom 
of the project team members. 
Table 5.6-Project limitations 
Factors Limitations / Assumptions 
3.1. Project's budget 339102,99 RUB 
3.1.1. Source of financing TPU, Laboratory for Isotopic Analysis 
and Technologies, 
3.2. Project timeline: 01-02-2021 to 28-05-2021 
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3.2.1. Date of approval of plan of project 14-03-2021 
3.2.2. Completion date 28-05-2021 
3.3. Other restrictions - 
 
4.3 Planning of scientific and technical project management 
The planning process group consists of the processes that are carried out to determine the 
overall content of the work, clarify the goals, and develop the sequence of actions required to 
achieve these goals. The scientific project management plan should include the following 
elements. 
4.3.1 Project Schedule 
As part of planning a science project, you need to build a project timeline and a Gantt Chart. 
Table 5.7- Project Schedule 











5 01-02-2021 06-02-2021 
Scientific 
supervisor                               
Determination of 
research direction 




Place of the on-
job training and 
experimental 
performance 








literature review  
23 15-02-2021 14-02-2021 Executor 
Preparations of 
chemical reagents 




of data from 
HPGe detector 




3 30-02-2021 13-03-2021 Executor  
Compiling the 
final document of 
dissertation 
15 13-03-2021 29-03-2021 Executor  
Adding and 
compiling new 




5 29-03-2021 07-04-2021 Executor 
Implementation 
of the corrections 
of the whole 
document 




















As part of planning a science project, you need to build a project timeline and a Gantt 
Chart. Hierarchical Work Structure (HWS) - detailing the enlarged work structure. In the 
process of creating an HWS, the content of the entire project is structured and defined. It may 
be presented in schemes. 
As part of planning a science project, you need to build a project timeline and a Gantt 
Chart. A Gantt chart, or harmonogram, is a type of bar chart that illustrates a project schedule. 
This chart lists the tasks to be performed on the vertical axis, and time intervals on the 












Table 5.8- A Gantt charts 




Duration of the project 
February March April May 
1 2 3 1 2 3 1 2 3 1 2 3 
1 
Development 
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 Scientific supervisor                              Consultant                          Executor            
4.4 Scientific and technical research budget 
When planning the budget of scientific research, it should be ensured that all types of planned 
expenditures necessary for its implementation are fully and reliably reflected. In the process 





The calculation of material costs may be also carried out according to the formula: 
(25) 
where; 
m – the number of types of material resources consumed in the performance of scientific 
research; 
Nconsi – the amount of material resources of the i-th species planned to be used when 
performing scientific research (units, kg, m, m2, etc.); 
Pi – the acquisition price of a unit of the i-th type of material resources consumed (rub./units, 
rub./kg, rub./m, rub./m2, etc.); 
kТ – coefficient taking into account transportation costs. 
Prices for material resources can be set according to data posted on relevant websites 
on the Internet by manufacturers (or supplier organizations). 
Energy costs are calculated by the formula: 
(26) 
where; 
𝑃𝑒𝑙 − power rates (5.8 rubles per 1 kWh); 
Р − power of equipment, kW; 
𝐹𝑒𝑞 − equipment usage time, hours. 
4.4.1 Special equipment for scientific experiments 
This article includes all the costs associated with the purchase of special equipment 
(instruments, control and measuring equipment, stands, devices and mechanisms) necessary 
for carrying out work on a specific topic. The cost of special equipment is determined 




 𝐶𝑚 = (1 + 𝑘Т) ⋅ ∑ 𝑃𝑖 ⋅ 𝑁𝑐𝑜𝑛𝑠𝑖
𝑚
𝑖=1 ,      





Table 5.9-Cost calculation for the article «Special equipment for scientific experiments 
№ Name of equipment Quantity, 
units 
Price per unit, 
money, rub 
Total cost for 
position, 
money 
1 New laptop 1 42 000,00 42 000,00 
2 Pens  2 250,00 500,00 
 Books 2 157,00 314,00 
3 Transportation 2 320,00 640,00 
 Total  43454,00 
 
When purchasing special equipment, it is necessary to include in the costs its delivery and 
installation in the amount of 15 % of its price. The cost of equipment used in the 
implementation of a specific scientific project and available in this scientific and technical 
organization is accounted in the form of depreciation charges.  
4.5 Calculation of the depreciation 
 Depreciation is not charged if an equipment cost is less than 40 thousand rubles, its 
cost is taken into account in full. 
If you use available equipment, then you need to calculate depreciation: 
             𝐴 =
𝐶перв∗На
100
                                                                      (27) 
where; 
А - annual amount of depreciation; 




 - rate of depreciation; 
 Тсл  - life expectancy. 
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For this research, a HPGe detector (GX1018 Canberra), cementation and distillations 
equipment which cost 450 000,00 rubles, 233 520,00 rubles, 277 300 ,00 rub les were used. 
The gamma detector and the laptop both had a life expectancy of 5 years whiles that of the 
climatic chamber was 10 years. The depreciation for the gamma detector, climatic chamber 
and laptop can be calculated as follows: 
HPGe detector (GX1018 Canberra): 
                                                                   𝐷 =  
𝐶𝑜𝑠𝑡
𝑇𝑖𝑚𝑒
                                                            (28) 







Since the equipment was used for 6 days 
𝐴 = 246,58 × 6 = 1479,48 𝑟𝑢𝑏𝑙𝑒𝑠 
Cementation equipment: 











Since the equipment was used for 2 days 
𝐴 = 63,98 × 2 = 127,96 𝑟𝑢𝑏𝑙𝑒𝑠 
Distillation equipment: 











Since the equipment was used for 2 days 












































4.6 Basic salary 
This article includes the basic salary of scientific and engineering workers, workers of 
model workshops and experimental production facilities directly involved in the performance 
of work on this topic. The amount of salary expenses is determined based on the labor intensity 
of the work performed and the current system of remuneration. The basic salary includes a 
bonus paid monthly from the salary fund (the amount is determined by the Regulations on 
Remuneration of Labor).  
This point includes the basic salary of participants directly involved in the 
implementation of work on this research. The value of salary costs is determined based on the 
labor intensity of the work performed and the current salary system. The basic salary (Sb) is 






Sb – basic salary per participant; 
Тw – the duration of the work performed by the scientific and technical worker, working days; 
Sa - the average daily salary of an participant, rub. 




 – monthly salary of an participant, rub.; 
М – the number of months of work without leave during the year: 
at holiday in 48 days, M = 11.2 months, 6 day per week; 
– valid annual fund of working time of scientific and technical personnel (251 days). 
Table 5.11-The valid annual fund of working time 
Working time indicators  
Calendar number of days 365 






Loss of working time 
- vacation 
- sick absence 
48 









,       











Monthly salary is calculated by formula: 
(31) 
where;  
Sbase – base salary, rubles; 
kpremium – premium rate;  
kbonus – bonus rate; 
kreg – regional rate (for Tomsk region is equal 1.3). 
 

















- - 1,3 
89960,00 3087,81 18 55580,58 
Consultant  35800,00 46540,00 1597,45 33 52715,85 
Executor 8720,00    11336,00 642,53 79 50759,87 
Total  159056,30 
 
4.6.1 Additional salary 
This point includes the amount of payments stipulated by the legislation on labor, for 
example, payment of regular and additional holidays; payment of time associated with state 
and public duties; payment for work experience, etc. 
Additional salaries are calculated on the basis of 10-15% of the base salary of workers: 





Wadd – additional salary, rubles; 
kextra – additional salary coefficient (10%);  
Wbase – base salary, rubles. 
Table 5.13-Salary of scientific research project performers 
Salary Scientific 
supervisor 
Consultant Executor  
Basic salary 55580,58 52715,85 50759,87 
Additional salary 5558,06 5271,59 5075,99 
Total payments 
at article Csal 
15905,64 
 
4.6.2 Social security pays (Labor tax) 
Social security pays (so-called labor tax) to extra-budgetary funds are compulsory 
according to the norms established by the legislation of the Russian Federation to the state 
social insurance (SIF), pension fund (PF) and medical insurance (FCMIF) from the costs of 
workers. 
Payment to extra-budgetary funds is determined of the formula:  
(33) 
where; kb – coefficient of deductions for labor tax. 
In accordance with the Federal law of July 24, 2009 No. 212-FL, the amount of 
insurance contributions is set at 30%. Institutions conducting educational and scientific 
activities have rate - 27.1%. 
 𝑊𝑎𝑑𝑑 = 𝑘extra ⋅ 𝑊𝑏𝑎𝑠𝑒,    
 𝑃𝑠𝑜𝑐𝑖𝑎𝑙 = 𝑘𝑏 ⋅ (𝑊𝑏𝑎𝑠𝑒 + 𝑊𝑎𝑑𝑑)  
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Salary, rubles 61138,64 57987,44 55835,86 
Labor tax, rubles 16568,57 15714,60 15131,52 
Total 47414,69 
 
4.7 Scientific and industrial business trips  
This article includes the travel expenses of scientific and production personnel associated with 
the direct implementation of a scientific research project, the amount of which is assumed to 
be 10% of the main and additional salaries of all personnel engaged in the implementation of 
this topic. 
4.7.1 Pays for work performed by other firms 
This item includes the cost of counterparty work, i.e. work performed by third-party 
organizations and enterprises on the order of this scientific and technical organization, the 
results of which are used in a scientific research project. In addition, this item of expenditure 
includes the payment of consultations, the use of the Internet, etc. The amount of these costs 
is determined according to the contractual terms. 
4.7.2 Overhead costs 
Overhead costs include other management and maintenance costs that can be allocated 
directly to the project. In addition, this includes expenses for the maintenance, operation and 
repair of equipment, production tools and equipment, buildings, structures, etc. 
120 
 
Overhead costs account from 30% to 90% of the amount of basic and additional salary 
of employees. 
Overhead is calculated according to the formula: 
(34) 






Overhead rate 40% 
Salary, rubles 61138,64 57987,44 55835,86 
Overhead, rubles 24455,46 23194,98 22334,34 
Total 69984,78 
 
4.8 Other direct costs  
Energy costs for equipment are calculated by the formula: 
(35) 
where; 
elP  − power rates (5.8 rubles per 1 kWh); 
Р  − power of equipment, kW; 






 Сov = 𝑘𝑜𝑣 ⋅ (𝑊base + 𝑊𝑎𝑑𝑑)  
          el eqС P Р F=   , 
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HPGe detector (GX1018 
Canberra) 
5.8 0.5 480 1392 
Cementation equipment 5.8 0.5 24 69,60 
Distillation equipment 5.8 0.5 24 69,60 
Total  1531,2 
 
4.9 Determination of resource (resource-saving), financial, budgetary, social 
and economic efficiency of research 
The effectiveness of a scientific resource-saving project includes social efficiency, 
economic and budgetary efficiency. Public efficiency indicators take into account the socio-
economic consequences of the implementation of an investment project for society as a whole, 
including the direct results and costs of the project, as well as costs and benefits in related 
sectors of the economy, environmental, social and other non-economic effects. 
The indicators of the economic efficiency of the project take into account the financial 
implications of its implementation for the enterprise implementing the project. In this case, 
the performance indicators of the project as a whole characterize from an economic point of 
view, technical, technological and organizational design solutions. 
Budgetary efficiency is characterized by the participation of the state in the project in 
terms of expenditures and revenues of budgets of all levels. 
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In addition to the above types of efficiency, the resource effect can be distinguished 
(characterized by indicators reflecting the influence of innovation on the volume of production 
and consumption of one or another type of resource), scientific and technical (evaluated by 
indicators of novelty and usefulness), etc. 
4.9.1 Formation of budget costs 
The calculated cost of research is the basis for budgeting project costs. Determining 
the budget for the scientific research is given in the table 5.17. 
Table 5.17- Items expenses grouping 
Name Cost, rubles 
1. Material costs 43454,00 
2. Equipment costs 1756,38 
3. Basic salary 159056,30 
4. Additional salary 15905,64 
5. Labor tax 47414,69 
6. Overhead 69984,78 
7. Other direct costs  1531,2 
Total planned costs 339102,99 
 
4.10 Evaluation of the comparative efficiency of the scientific research project 
Determination of efficiency is based on the calculation of the integral indicator of the 
efficiency of scientific research. Its finding is associated with the determination of two 
weighted averages: financial efficiency and resource efficiency. 
An integral indicator of the financial efficiency of a scientific research is obtained in 
assessing the budget of costs of three (or more) variants of the implementation of a scientific 
research. For this, the largest integral indicator of the implementation of a technical problem 
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is taken as the basis of the calculation (as the denominator), with which the financial values 
for all execution options are correlated. 
Integral financial indicator is determined in the formula:  
           (36) 
where; 
 If p  
 – integral financial indicator of current project; 
Fрi – price for i-th variant of execution;  
Fmax – maximum cost of execution of a research project (including analogs). 
The resulting value of the integral financial indicator of development reflects the 
corresponding numerical increase in the budget of development costs in times (a value greater 
than one), or the corresponding numerical reduction in the cost of development in times (a 
value less than one, but higher than zero). 
Where; 
 Fpi – the cost of the research work for using cementation cycle = 339102,99; 
And Fmax – the maximum cost of execution of research project using an electrochemical 























The integral indicator of the resource efficiency of the variants of the object of 
research can be defined as follows: 
,    (37) 
where;  
Im
a is an integral indicator of resource efficiency of options; 
ai- the weight coefficient of the i-th parameter; 
 - the score of the i-th parameter for the analog and development, set by an expert 
method on the selected rating scale; 
n - the number of comparison parameters. 
It is recommended to calculate the integral resource efficiency indicator in the form 



















Growth in User’ productivity 0.1 3 5 
Convenience in operation (meets 
the requirements of consumers) 
0.15 4 4 
Immunity 0.15 2 4 
Energy efficiency 0.20 4 2 
Reliability 0.25 4 3 
Material consumption 0.15 3 5 
Total 1 20 23 
 
𝐼𝑎𝑚  = 3*0,1+4*0,15+2*0.15+4*0,20+4*0,25+3*0,15=3,45 
Analog’s 1 = 5*0,1+4*0,15+4*0,15+2*0,20+3*0,25+5*0,15=3,60 
An integral efficiency indicator of the scientific research project (I fin p) and of the 
analog (I fin a) are determined according to the formula of the integral basis of the financial 
integral resource efficiency: 

















Comparison of the integral indicator of the efficiency of the current project and 
analogs will determine the comparative efficiency the project. Comparative project efficiency: 
                                      (39) 
where;  
E av is the comparative project efficiency;  
 I fin p - integral indicator of project;  





Table 5.19-Comparative project efficiency 
№ Indicator Project Analog 1 
(electrochemical 
method) 
1 Integral financial indicator 0,81 1 
2 Integral resource efficiency 
indicator 
3,45 3,60 
3 Integral efficiency indicator 1,18 1 
4 Comparative evaluation of the 
project execution variants 
1,18 1 
 
Comparison of the values of integral indicators of efficiency allows master’s students 
to choose a more effective solution to the technical problem in the master's thesis basing on 
financial and resource efficiency. 
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Conclusions of Financial Management 
Observations from the calculated results above, it can be concluded that the best place 
to conduct this research work is project which is the university, in order to attain resource and 
financial efficiency. 
Thus, in this section was developed stages for design and create competitive 
development that meet the requirements in the field of resource efficiency and resource 
saving. 
These stages include: 
- development of a common economic project idea, formation of a project 
concept; 
- organization of work on a research project; 
- identification of possible research alternatives; 
- research planning; 
- assessing the commercial potential and prospects of scientific research 
from the standpoint of resource efficiency and resource saving; 
- determination of resource (resource saving), financial, budget, social and 
economic efficiency of the project. 
In the course of performing the economic part of the qualification master work, 
calculations were made of the planned cost of research and the time spent. The total cost of 
work is 339102,99 RUB, the main component of which is the cost of wages to perform 







Chapter 5-Social responsibility 
5.1 Introduction 
The social responsibility concerning the workplace is very paramount to the safety 
and well-being of the workers and the people around. The human life is so important that 
nothing can replace it when damaged or death. This is the reason why there should be radical 
improvement in safety techniques in the working environment to reduce accident rates. 
The working environment involved in this research is mainly based on producing 
177Lu from natural enriched Yb2O3 target (indirect route) for nuclear medicine applications. 
Hence, the workplace involved the laboratory rooms which includes preparation of chemicals 
and gamma spectroscopy equipment for collection of data and results analysis.  
The objective of the study is to determine the theoretical specific activity of 177Lu. The 
theoretical activity and specific activity calculations of 177Lu from the given problem of 
Yb2O3. Cementation process using non-radioactive amount of Yb2O3 and distillation process. 
To measure the activity using the well-type HPGe gamma-ray detector (GX1018 Canberra). 
To calculate the activity of Yb and Lu from gamma-ray lines detected results. 
Cementation process is performed to separate Yb from Lu followed by the extraction 
of Hg using distillation process. The radioisotope 177Lu produced by indirect route may 
produces a low specific activity due to low thermal cross section of Yb, therefore, suitable 
separation method is required for producing high yield of 177Lu. 
5.2 Legal and organizational items in providing safety 
Nowadays one of the main ways to radical improvement of all prophylactic work 
referred to reduce Total Incidents Rate and occupational morbidity is the widespread 
implementation of an integrated Occupational Safety and Health management system. That 
means combining isolated activities into a single system of targeted actions at all levels and 
stages of the production process. 
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Occupational Safety in the workplace is a system of legislative, socio-economic, 
technological, organizational, therapeutic and prophylactic actions and tools that is taken to 
ensure the safety, protection of the human health and the optimum performance of the human 
during working hours [1]. However, there should be laid down rules for labor protection and 
safety tactics that should be enacted in the working environment in order to prevent accidents 
and to guarantee safe and reliable working atmosphere on the part of the workers as 
obligatory. These should cover all workers from the highest hierarchy to the lowest rank in 
exception to none.   
According to the Labor Code of the Russian Federation, every employee has the right: 
- to have a workplace that meets Occupational safety requirements; 
- to have a compulsory social insurance against accidents at manufacturing and 
occupational diseases; 
- to receive reliable information from the employer, relevant government bodies and 
public organizations on conditions and Occupational safety at the workplace, about the 
existing risk of damage to health, as well as measures to protect against harmful and (or) 
hazardous factors; 
- to refuse carrying out work in case of danger to his life and health due to violation 
of Occupational safety requirements; 
- be provided with personal and collective protective equipment in compliance with 
Occupational safety requirements at the expense of the employer; 
- for training in safe work methods and techniques at the expense of the employer; 
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- for personal participation or participation through their representatives in 
consideration of issues related to ensuring safe working conditions in his workplace, and in 
the investigation of the accident with him at work or occupational disease; 
- for extraordinary medical examination in accordance with medical recommendations 
with preservation of his place of work (position) and secondary earnings during the passage 
of the specified medical examination; 
- for warranties and compensation established in accordance with this Code, collective 
agreement, agreement, local regulatory an act, an employment contract, if he is engaged in 
work with harmful and (or) hazardous working conditions. 
The labor code of the Russian Federation states that normal working hours may not 
exceed 40 hours per week. The employer must keep track of the time worked by each 
employee. 
Rules for labor protection and safety measures are introduced in order to prevent 
accidents, ensure safe working conditions for workers and are mandatory for workers, 
managers, engineers and technicians. 
In the industries, there are dangerous factors whose impact under certain 
circumstances might led to trauma, sudden shock and severe worsening of the health of the 
worker. Therefore, a harmful factor or an industrial health hazard is a factor whose effect on 
a worker under certain conditions may result to a decrease in the working capacity which has 
a direct negative influence on productivity of the workplace. 
5.3 Basic ergonomic requirements for the correct location and arrangement of 
researcher’s workplace  
The workplace when working with a PC should be at least 6 square meters. The 
legroom should correspond to the following parameters: the legroom height is at least 600 
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mm, the seat distance to the lower edge of the working surface is at least 150 mm, and the 
seat height is 420 mm. It is worth noting that the height of the table should depend on the 
growth of the operator. 
The following requirements are also provided for the organization of the workplace of 
the PC user: The design of the working chair should ensure the maintenance of a rational 
working posture while working on the PC and allow the posture to be changed in order to 
reduce the static tension of the neck and shoulder muscles and back to prevent the 
development of fatigue. 
The type of working chair should be selected taking into account the growth of the 
user, the nature and duration of work with the PC. The working chair should be lifting and 
swivel, adjustable in height and angle of inclination of the seat and back, as well as the 
distance of the back from the front edge of the seat, while the adjustment of each parameter 
should be independent, easy to carry out and have a secure fit. 
5.4 Occupational safety  
A dangerous factor or industrial hazard is a factor whose impact under certain 
conditions leads to trauma or other sudden, severe deterioration of health of the worker [1]. 
A harmful factor or industrial health hazard is a factor, the effect of which on a worker 
under certain conditions leads to a disease or a decrease in working capacity. 
5.4.1 Analysis of harmful and dangerous factors that can create object of 
investigation  
The object of NCA 177Lu is radioactive material which is used for treatment of cancer 
for patients, therefore cannot causes any harmful and dangerous factors. 
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5.4.2 Analysis of harmful and dangerous factors that can arise at workplace 
during investigation  
The workplace is characterized by circumstances involving hazardous and harmful 
factors. These factors are grouped into distinct categories namely; biological, physical, 
chemical, and psychophysiological. The main elements of the production process that form 
dangerous and harmful factors are presented in Table 6.1 below. 




Work stages Legal 
documents Development Manufacture Exploitation 
1. Deviation of 
microclimate 
indicators 























































































+ + + Sanitary Rules 







There are several factors that have great influence on the person working on the 
computers and these factors are classified based on physical and psychophysiological effects 
are as follows. 
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The following factors effect on person working on a computer: 
- physical:  
o temperature and humidity;  
o noise;  
o static electricity;  
o electromagnetic field of low purity; 
o illumination; 
o presence of radiation; 
-  psychophysiological: 
o  psychophysiological dangerous and harmful factors are divided into:  
- physical overload (static, dynamic)  
- mental stress (mental overstrain, monotony of work, emotional 
overload). 
The following Table 2 explain further these factors: 
5.4.2.1 Deviation of microclimate indicators 
The air of the working area (microclimate) is determined by the following parameters: 
temperature, relative humidity, air speed. The optimum and permissible values of the 







Table 6.2 – Physical and psychophysiological factors and its effects in a computer 









Temperature and humidity: Sometimes, humans in general 
feels so tired and disturbed due to the hotness, coldness and 
the moisture content in an enclosed environment. Hence, 
these conditions may sometimes reduce the productivity 
and affects the physical well-being of the worker.  
 
Noise: Continual background noise from the computer 
systems sometimes has a physical damage on the hearing 
organ of the worker. This damage may continue to affect the 
person each day, weeks, months and years.   
 
Static electricity: this an inequity of electrical charges on the 
surface or within a material which exist around a field until 
its able dissipate through an electric current or an electrical 
discharge. One main physical effect of static electricity to 
the worker is having an airborne particulate influence on 
him. For instance, if a worker is positively charged, it has 
the possibility of attracting negatively charged particles 
from the air around him, hence setting up static electric field 
which is unhygienic and causes other problems.  Many 
scientific findings have established that electric fields 
around a person intensely increase the plate-out rate of 
airborne particulates.  Hence, from speculations, it’s been 
point out that incase such particulates has an allergic effect, 
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the plate-out might cause an incidence of skin irritation or 
disease, though has not proved.  
 
 Electromagnetic field of low purity  
 
Illumination: Lightening from the monitor screen of 
the computer has a direct effect on the eye of the worker 
involved. Spending many hours working with the computer 
has a blurry effect on the eye and as a sign of digital strain 
on the eye. The most damaging of all is too much exposure 






Physical overload (static, dynamic)  
 
Mental stress: Sitting at one place for a long time 
with the computer by straining the eye, involving the brain 
with much work may result in mental overstrain, monotony 
of work, emotional overload and many more that have 








Table 6.3 - Optimal and permissible parameters of the microclimate 
 
5.4.2.2 Excessive noise 
Noise and vibration worsen working conditions, have a harmful effect on the human 
body, namely, the organs of hearing and the whole body through the central nervous system. 
It results in weakened attention, deteriorated memory, decreased response, and increased 
number of errors in work. Noise can be generated by operating equipment, air conditioning 
units, daylight illuminating devices, as well as spread from the outside. When working on a 
PC, the noise level in the workplace should not exceed 50 dB. 
5.4.2.3 Increased level of electromagnetic radiation 
The screen and system blocks produce electromagnetic radiation. Its main part comes 
from the system unit and the video cable. According to [2], the intensity of the electromagnetic 
field at a distance of 50 cm around the screen along the electrical component should be no 
more than: 
- in the frequency range 5 Hz - 2 kHz - 25 V / m; 
- in the frequency range 2 kHz - 400 kHz - 2.5 V / m. 
The magnetic flux density should be no more than: 
- in the frequency range 5 Hz - 2 kHz - 250 nT; 
- in the frequency range 2 kHz - 400 kHz - 25 nT. 
Period of the year Temperature, C 
Relative 
humidity,% 
Speed of air 
movement, m/s 
Cold and changing 
of seasons 
23-25 40-60 0.1 
Warm 23-25 40 0.1 
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5.4.2.4 Abnormally high voltage value in the circuit 
Depending on the conditions in the room, the risk of electric shock to a person 
increases or decreases. Do not operate the electronic device in conditions of high humidity 
(relative air humidity exceeds 75% for a long time), high temperature (more than 35 ° C), the 
presence of conductive dust, conductive floors and the possibility of simultaneous contact 
with metal components connected to the ground and the metal casing of electrical equipment. 
The operator works with electrical devices: a computer (display, system unit, etc.) and 
peripheral devices. There is a risk of electric shock in the following cases: 
- with direct contact with current-carrying parts during computer repair; 
- when touched by non-live parts that are under voltage (in case of violation of 
insulation of current-carrying parts of the computer); 
- when touched with the floor, walls that are under voltage; 
- short-circuited in high-voltage units: power supply and display unit. 
Table 6.4 - Upper limits for values of contact current and voltage 
 Voltage, V Current, mA 
Alternate,  50 Hz 2 0.3 
Alternate,  400 Hz 3 0.4 
Direct 8 1.0 
 
5.4.2.5 Insufficient illumination of the working area 
Light sources can be both natural and artificial. The natural source of the light in the 
room is the sun, artificial light are lamps. With long work in low illumination conditions and 
in violation of other parameters of the illumination, visual perception decreases, myopia, eye 
disease develops, and headaches appear. 
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According to the standard, the illumination on the table surface in the area of the 
working document should be 300-500 lux. Lighting should not create glare on the surface of 
the monitor. Illumination of the monitor surface should not be more than 300 lux. 
The brightness of the lamps of common light in the area with radiation angles from 50 
to 90° should be no more than 200 cd/m, the protective angle of the lamps should be at least 
40°. The safety factor for lamps of common light should be assumed to be 1.4. The ripple 
coefficient should not exceed 5%. 
5.4.2.6 Increased levels of ionizing radiation (Gamma spectroscopy) 
Ionizing radiation is radiation that could ionize molecules and atoms. This effect is 
widely used in energetics and industry. However, there is health hazard. In living tissue, this 
radiation could damage cells that result in two types of effects. Deterministic effects (harmful 
tissue reactions) due to exposure with high doses and stochastic effects due to DNA 
destruction and mutations (for example, induction of cancer). 
To provide radiation safety with using sources of ionizing radiation one must use next 
principles: 
a) keep individual radiation doses from all radiation sources not higher than 
permissible exposure; 
b) forbid all activity with using radiation sources if profit is low than risk of possible 
hazard; 
c) keep individual radiation doses from all radiation sources as low as possible. 
There are two groups of people related to work with radiation: personnel, who works 
with ionizing radiation, and population. 
Quantity Dose limits 
personnel population 
Effective dose 20 mSv per year in 
average during 5 years, 
1 mSv per year in 
average during 5 years, 
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but not higher than 50 
mSv per year 
but not higher than 5 
mSv per year 
Equivalent 
dose per year 
in eye’s lens 
 
150 mSv 15 mSv 
skin 500 mSv 50 mSv 
Hands and feet 500 mSv 50 mSv 
  
Effective dose for personnel must not exceed 1000 mSv for 50 years of working 
activity, and for population must not exceed 70 mSv for 70 years of life. 
In addition, for women from personnel of age below 45 years there is limit of 1 mSv 
per month of equivalent dose on lower abdomen. During gestation and breast feeding women 
must not work with radiation sources. 
For students older than 16, who uses radiation sources in study process or who is in 
rooms with increased level of ionizing radiation, dose limits are quarter part of dose limits of 
personnel. 
5.4.3 Justification of measures to reduce the levels of exposure to hazardous and 
harmful factors on the researcher 
5.4.3.1 Deviation of microclimate indicators 
The measures for improving the air environment in the production room include: the 
correct organization of ventilation and air conditioning, heating of room. Ventilation can be 
realized naturally and mechanically. In the room, the following volumes of outside air must 
be delivered:  
- at least 30 m 3 per hour per person for the volume of the room up to 20 
m 3 per person;  
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- natural ventilation is allowed for the volume of the room more than 40 
m 3 per person and if there is no emission of harmful substances. 
The heating system must provide sufficient, constant and uniform heating of the air. 
Water heating should be used in rooms with increased requirements for clean air.  
The parameters of the microclimate in the laboratory regulated by the central heating 
system, have the following values: humidity 40%, air speed 0.1 m / s, summer temperature 
20-25 ° C, in winter 13-15 ° C. Natural ventilation is provided in the laboratory. Air enters 
and leaves through the cracks, windows, doors. The main disadvantage of such ventilation is 
that the fresh air enters the room without preliminary cleaning and heating. 
5.4.3.2 Excessive noise 
In research audiences, there are various kinds of noises that are generated by both 
internal and external noise sources. The internal sources of noise are working equipment, 
personal computer, printer, ventilation system, as well as computer equipment of other 
engineers in the audience. If the maximum permissible conditions are exceeded, it is sufficient 
to use sound-absorbing materials in the room (sound-absorbing wall and ceiling cladding, 
window curtains). To reduce the noise penetrating outside the premises, install seals around 
the perimeter of the doors and windows. 
5.4.3.3 Increased level of electromagnetic radiation 
There are the following ways to protect against EMF: 
- increase the distance from the source (the screen should be at least 50 cm from the 
user); 
- the use of pre-screen filters, special screens and other personal protective equipment. 
When working with a computer, the ionizing radiation source is a display. Under the 
influence of ionizing radiation in the body, there may be a violation of normal blood 
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coagulability, an increase in the fragility of blood vessels, a decrease in immunity, etc. The 
dose of irradiation at a distance of 20 cm to the display is 50 µrem / hr. According to the 
norms [2], the design of the computer should provide the power of the exposure dose of x-
rays at any point at a distance of 0.05 m from the screen no more than 100 µR / h. 
Fatigue of the organs of vision can be associated with both insufficient illumination 
and excessive illumination, as well as with the wrong direction of light. 
5.4.3.4 Increased levels of ionizing radiation 
In case of radiation accident, responsible personnel must take all measures to restore 
control of radiation sources and reduce to minimum radiation doses, number of irradiated 
persons, radioactive pollution of the environment, economic and social losses caused with 
radioactive pollution. 
Radiation control is a main part of radiation safety and radiation protection.  It is aimed 
at not exceeding the established basic dose limits and permissible levels of radiation, obtaining 
the necessary information to optimize protection and making decisions about interference in 
the case of radiation accidents, contamination of the environment and buildings with 
radionuclides. 
The radiation control is control of: 
• Radiation characteristics of radiation sources, pollution in air, liquid and solid 
wastes. 
• Radiation factors developed with technological processes in working places and 
environment. 
• Radiation factors of contaminated environment. 
• Irradiation dose levels of personnel and population. 
The main controlled parameters are: 
• Annual effective and equivalent doses 
• intake and body content of radionuclides 
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• volume or specific activity of radionuclides in air, water, food products, building 
materials and etc. 
• radioactive contamination of skin, clothes, footwear, working places and etc. 
• dose and power of external irradiation. 
• particles and photons flux density. 
Radiation protection office establish control levels of all controlled parameters in 
according to not exceed dose limits and keep dose levels as low as possible. In case of 
exceeding control levels radiation protection officers start investigation of exceed 
causes and take actions to eliminate this exceeding. 
uring planning and implementation of radiation safety precautions, taking any 
actions about radiation safety and analysis of effectiveness of mentioned action and 
precautions one must value radiation safety with next factors: 
• characteristics of radioactive contamination of the environment; 
• probability of radiation accidents and scale of accidents; 
• degree of readiness to effective elimination of radiation accidents and its 
aftermathches;  
• number of persons irradiated with doses higher than controlled limits of doses; 
• analysis of actions for providing radiation safety, meeting requirements, rules, 
standards of radiation safety; 
• analysis of irradiation doses obtained by groups of population from all ionizing 
radiation sources. 
5.4.3.5 Abnormally high voltage value in the circuit 
Measures to ensure the electrical safety of electrical installations: 
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- disconnection of voltage from live parts, on which or near to which work will be 
carried out, and taking measures to ensure the impossibility of applying voltage to the 
workplace; 
- posting of posters indicating the place of work; 
- electrical grounding of the housings of all installations through a neutral wire; 
- coating of metal surfaces of tools with reliable insulation; 
- inaccessibility of current-carrying parts of equipment (the conclusion in the case 
of electroporating elements, the conclusion in the body of current-carrying parts) [3]. 
5.5 Ecological safety 
 5.5.1 Analysis of the impact of the research object on the environment 
 Sources of ionizing radiation used in medicine could be divided into two groups: 
radioactive substances and radiation generators. The difference is that radiation generators 
like accelerators and x-ray tubes emit ionizing radiation only when they are turned on.   
In ordinary work with necessary safety precautions, there are insignificant impact of 
using sources of ionizing radiation on environment. The immediate effect of ionizing 
radiation is ionization of air in room, but after a specified time the ionization disappears. 
The danger of using radioactive materials could occur only in accidents with stealing 
and loosing these materials due to high toxicity. 
5.5.2 Analysis of the environmental impact of the research process 
Process of investigation itself in the thesis do not have essential effect on 
environment. One of hazardous waste is fluorescent lamps. Mercury in fluorescent lamps is 
a hazardous substance and its improper disposal greatly poisons the environment. 
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Outdated devices goes to an enterprise that has the right to process wastes. It is 
possible to isolate precious metals with a purity in the range of 99.95–99.99% from 
computer components. A closed production cycle consists of the following stages: primary 
sorting of equipment; the allocation of precious, ferrous and non-ferrous metals and other 
materials; melting; refining and processing of metals. Thus, there is an effective disposal of 
computer devices. 
 5.5.3 Justification of environmental protection measures 
Pollution reduction is possible due to the improvement of devices that produces 
electricity, the use of more economical and efficient technologies, the use of new methods for 
generating electricity and the introduction of modern methods and methods for cleaning and 
neutralizing industrial waste. In addition, this problem should be solved by efficient and 
economical use of electricity by consumers themselves. This is the use of more economical 
devices, as well as efficient regimes of these devices. This also includes compliance with 
production discipline in the framework of the proper use of electricity. 
Simple conclusion is that it is necessary to strive to reduce energy consumption, to 
develop and implement systems with low energy consumption. In modern computers, modes 
with reduced power consumption during long-term idle are widely used. 
 5.6 Safety in emergency 
 5.6.1 Analysis of probable emergencies that may occur at the workplace during 
research 
The fire is the most probable emergency in our life. Possible causes of fire: 
- malfunction of current-carrying parts of installations; 
- work with open electrical equipment; 
- short circuits in the power supply; 
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- non-compliance with fire safety regulations; 
- presence of combustible components: documents, doors, tables, cable 
insulation, etc. 
Activities on fire prevention are divided into: organizational, technical, operational 
and regime. 
5.6.2 Substantiation of measures for the prevention of emergencies and the 
development of procedures in case of emergencies 
Organizational measures provide for correct operation of equipment, proper 
maintenance of buildings and territories, fire instruction for workers and employees, training 
of production personnel for fire safety rules, issuing instructions, posters, and the existence of 
an evacuation plan. 
The technical measures include compliance with fire regulations, norms for the design 
of buildings, the installation of electrical wires and equipment, heating, ventilation, lighting, 
the correct placement of equipment. 
The regime measures include the establishment of rules for the organization of work, 
and compliance with fire-fighting measures. To prevent fire from short circuits, overloads, 
etc., the following fire safety rules must be observed: 
- elimination of the formation of a flammable environment (sealing equipment, 
control of the air, working and emergency ventilation); 
- use in the construction and decoration of buildings of non-combustible or 
difficultly combustible materials; 
- the correct operation of the equipment (proper inclusion of equipment in the 
electrical supply network, monitoring of heating equipment); 
- correct maintenance of buildings and territories (exclusion of the source of ignition 
- prevention of spontaneous combustion of substances, restriction of fire works); 
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- training of production personnel in fire safety rules; 
- the publication of instructions, posters, the existence of an evacuation plan; 
- compliance with fire regulations, norms in the design of buildings, in the 
organization of electrical wires and equipment, heating, ventilation, lighting; 
- the correct placement of equipment; 
- well-time preventive inspection, repair and testing of equipment. 
In the case of an emergency, it is necessary to: 
- inform the management (duty officer); 
- call the Emergency Service or the Ministry of Emergency Situations - 
tel. 112; 


















 Conclusions of Social Responsibilities  
In this section about social responsibility the hazardous and harmful factors were 
revealed. All necessary safety measures and precaution to minimize probability of accidents 
and traumas during investigation are given.  
Possible negative effect on environment were given in compact form describing 
main ecological problem of using nuclear energy.  
It could be stated that with respect to all regulations and standards, investigation 
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Chapter 6-Conclusions and Future Recommendation  
The goal of the study was to perform the experimental production of NCA 177Lu with 
a recycling of the Yb target for nuclear medicine applications. The radioisotope 177Lu was 
separated from Yb target material for NCA experiment for nuclear medicine applications. The 
theoretical activity and specific activity of 177Lu from Yb2O3 were determined. The theoretical 
activity of  177Lu from 10 mg of Yb2O3  for 5 days is approximately 1 GBq. The cementation 
process was performed with five cementation experiments (each with three cementation 
cycles) using the ratio Lu/Yb 1000 followed by the recycling Yb.  
HPGe detector (GX1018 Canberra) was calibrated with 152Eu source for analysis of 
177Lu in the presence of Yb. Gamma-ray peak of 208 keV for 177Lu and 198 keV for 169Yb 
were detected in the system. The activity of the third cementation process of radioactive 
Yb and Lu were found to be 2.06±0.05 Bq and 96.97±4.16 Bq which corresponds to 1.4 
mg and 7.6 μg, respectively.The repeatability of the experiment was < 3.0 %, respectively. 
The ratio Yb/Lu of the third cementation process is about 184.2, separation factor is 5.4. 
After the cementation process, Yb target was extracted by distillation process, and the 
amount of Yb (mg) which that can be recycling is 35.5 mg from 51.4 mg (>69%) for new 
production.  After the cementation process, high amount of mass of Yb was observed. In 
conclusion, it is necessary to carry out optimization for better separation of Yb and Lu. The 
goal of this research was accomplished towards the production of radioisotopes 177Lu. 
For future recommendations,  the optimization must be carried out by changing the  
concentration NaCH3COONa, increase number of cementation cycles for better separation. 
To conduct the experiment with high activity. To determine the radionuclide and 
radiochemical purity. To measure the amount of impurities in production and to determine 
the synthases of 177Lu-DOTA-TATE. The outcome will ultimately provide evidence-based 
information, to the policy makers, about the contribution of the produced 177Lu to be used 
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